id	sid	tid	token	lemma	pos
work_wn6awlddpbeztpigfwaxuan4au	1	1	PMS40	PMS40	NNP
work_wn6awlddpbeztpigfwaxuan4au	1	2	UTILITY	UTILITY	NNP
work_wn6awlddpbeztpigfwaxuan4au	1	3	AND	and	CC
work_wn6awlddpbeztpigfwaxuan4au	1	4	QUALITY	QUALITY	NNP
work_wn6awlddpbeztpigfwaxuan4au	1	5	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	1	6	LIFE	life	NN
work_wn6awlddpbeztpigfwaxuan4au	1	7	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	1	8	PATIENTS	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	1	9	WITH	with	IN
work_wn6awlddpbeztpigfwaxuan4au	1	10	OSTEOARTHRITIS	osteoarthriti	NNS
work_wn6awlddpbeztpigfwaxuan4au	1	11	TREATED	treated	JJ
work_wn6awlddpbeztpigfwaxuan4au	1	12	WITH	with	IN
work_wn6awlddpbeztpigfwaxuan4au	1	13	THE	the	DT
work_wn6awlddpbeztpigfwaxuan4au	1	14	CYCLOOXYGENASE	CYCLOOXYGENASE	NNP
work_wn6awlddpbeztpigfwaxuan4au	1	15	INHIBITING	INHIBITING	NNP
work_wn6awlddpbeztpigfwaxuan4au	1	16	NITRIC	nitric	NN
work_wn6awlddpbeztpigfwaxuan4au	1	17	OXIDE	OXIDE	NNPS
work_wn6awlddpbeztpigfwaxuan4au	1	18	DONATOR	DONATOR	NNP
work_wn6awlddpbeztpigfwaxuan4au	1	19	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	1	20	CINOD	CINOD	NNP
work_wn6awlddpbeztpigfwaxuan4au	1	21	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	1	22	NAPROXCINOD	NAPROXCINOD	NNP
work_wn6awlddpbeztpigfwaxuan4au	1	23	Abstracts	Abstracts	NNPS
work_wn6awlddpbeztpigfwaxuan4au	1	24	A71	A71	NNP
work_wn6awlddpbeztpigfwaxuan4au	1	25	symptom	symptom	NN
work_wn6awlddpbeztpigfwaxuan4au	1	26	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	1	27	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	2	1	The	the	DT
work_wn6awlddpbeztpigfwaxuan4au	2	2	Health	Health	NNP
work_wn6awlddpbeztpigfwaxuan4au	2	3	Assessment	Assessment	NNP
work_wn6awlddpbeztpigfwaxuan4au	2	4	Questionnaire	Questionnaire	NNP
work_wn6awlddpbeztpigfwaxuan4au	2	5	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	2	6	HAQ	HAQ	NNP
work_wn6awlddpbeztpigfwaxuan4au	2	7	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	2	8	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	2	9	used	use	VBN
work_wn6awlddpbeztpigfwaxuan4au	2	10	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	2	11	measure	measure	VB
work_wn6awlddpbeztpigfwaxuan4au	2	12	func-	func-	JJ
work_wn6awlddpbeztpigfwaxuan4au	2	13	tional	tional	JJ
work_wn6awlddpbeztpigfwaxuan4au	2	14	status	status	NN
work_wn6awlddpbeztpigfwaxuan4au	2	15	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	2	16	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	2	17	0–3	0–3	NFP
work_wn6awlddpbeztpigfwaxuan4au	2	18	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	2	19	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	3	1	QoL	QoL	NNP
work_wn6awlddpbeztpigfwaxuan4au	3	2	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	3	3	measured	measure	VBN
work_wn6awlddpbeztpigfwaxuan4au	3	4	by	by	IN
work_wn6awlddpbeztpigfwaxuan4au	3	5	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	3	6	mental	mental	JJ
work_wn6awlddpbeztpigfwaxuan4au	3	7	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	3	8	MCS	MCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	3	9	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	3	10	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	3	11	physical	physical	JJ
work_wn6awlddpbeztpigfwaxuan4au	3	12	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	3	13	PCS	PCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	3	14	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	3	15	component	component	VBP
work_wn6awlddpbeztpigfwaxuan4au	3	16	summary	summary	NN
work_wn6awlddpbeztpigfwaxuan4au	3	17	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	3	18	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	3	19	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	3	20	Short	Short	NNP
work_wn6awlddpbeztpigfwaxuan4au	3	21	Form-8	Form-8	NNP
work_wn6awlddpbeztpigfwaxuan4au	3	22	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	3	23	SF-8	SF-8	NNP
work_wn6awlddpbeztpigfwaxuan4au	3	24	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	3	25	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	4	1	Work	work	NN
work_wn6awlddpbeztpigfwaxuan4au	4	2	/	/	SYM
work_wn6awlddpbeztpigfwaxuan4au	4	3	productivity	productivity	NN
work_wn6awlddpbeztpigfwaxuan4au	4	4	loss	loss	NN
work_wn6awlddpbeztpigfwaxuan4au	4	5	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	4	6	measured	measure	VBN
work_wn6awlddpbeztpigfwaxuan4au	4	7	by	by	IN
work_wn6awlddpbeztpigfwaxuan4au	4	8	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	4	9	Work	Work	NNP
work_wn6awlddpbeztpigfwaxuan4au	4	10	Productivity	Productivity	NNP
work_wn6awlddpbeztpigfwaxuan4au	4	11	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	4	12	Activity	Activity	NNP
work_wn6awlddpbeztpigfwaxuan4au	4	13	Impairment	Impairment	NNP
work_wn6awlddpbeztpigfwaxuan4au	4	14	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	4	15	WPAI	WPAI	NNP
work_wn6awlddpbeztpigfwaxuan4au	4	16	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	4	17	instrument	instrument	NN
work_wn6awlddpbeztpigfwaxuan4au	4	18	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	5	1	Comparisons	comparison	NNS
work_wn6awlddpbeztpigfwaxuan4au	5	2	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	5	3	made	make	VBN
work_wn6awlddpbeztpigfwaxuan4au	5	4	between	between	IN
work_wn6awlddpbeztpigfwaxuan4au	5	5	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	5	6	who	who	WP
work_wn6awlddpbeztpigfwaxuan4au	5	7	currently	currently	RB
work_wn6awlddpbeztpigfwaxuan4au	5	8	use	use	VBP
work_wn6awlddpbeztpigfwaxuan4au	5	9	SC	SC	NNP
work_wn6awlddpbeztpigfwaxuan4au	5	10	biologics	biologic	NNS
work_wn6awlddpbeztpigfwaxuan4au	5	11	versus	versus	IN
work_wn6awlddpbeztpigfwaxuan4au	5	12	those	those	DT
work_wn6awlddpbeztpigfwaxuan4au	5	13	who	who	WP
work_wn6awlddpbeztpigfwaxuan4au	5	14	discontinued	discontinue	VBD
work_wn6awlddpbeztpigfwaxuan4au	5	15	treatment	treatment	NN
work_wn6awlddpbeztpigfwaxuan4au	5	16	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	6	1	RESULTS	RESULTS	NNP
work_wn6awlddpbeztpigfwaxuan4au	6	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	6	3	Of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	6	4	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	6	5	2,200	2,200	CD
work_wn6awlddpbeztpigfwaxuan4au	6	6	survey	survey	NN
work_wn6awlddpbeztpigfwaxuan4au	6	7	respondents	respondent	NNS
work_wn6awlddpbeztpigfwaxuan4au	6	8	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	6	9	72	72	CD
work_wn6awlddpbeztpigfwaxuan4au	6	10	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	6	11	female	female	JJ
work_wn6awlddpbeztpigfwaxuan4au	6	12	;	;	:
work_wn6awlddpbeztpigfwaxuan4au	6	13	average	average	JJ
work_wn6awlddpbeztpigfwaxuan4au	6	14	age	age	NN
work_wn6awlddpbeztpigfwaxuan4au	6	15	49.6years	49.6year	NNS
work_wn6awlddpbeztpigfwaxuan4au	6	16	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	6	17	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	6	18	386	386	CD
work_wn6awlddpbeztpigfwaxuan4au	6	19	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	6	20	17.5	17.5	CD
work_wn6awlddpbeztpigfwaxuan4au	6	21	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	6	22	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	6	23	used	use	VBN
work_wn6awlddpbeztpigfwaxuan4au	6	24	SC	SC	NNP
work_wn6awlddpbeztpigfwaxuan4au	6	25	biologics	biologic	NNS
work_wn6awlddpbeztpigfwaxuan4au	6	26	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	7	1	The	the	DT
work_wn6awlddpbeztpigfwaxuan4au	7	2	average	average	JJ
work_wn6awlddpbeztpigfwaxuan4au	7	3	dura-	dura-	JJ
work_wn6awlddpbeztpigfwaxuan4au	7	4	tion	tion	NN
work_wn6awlddpbeztpigfwaxuan4au	7	5	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	7	6	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	7	7	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	7	8	12.4	12.4	CD
work_wn6awlddpbeztpigfwaxuan4au	7	9	years	year	NNS
work_wn6awlddpbeztpigfwaxuan4au	7	10	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	7	11	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	7	12	14	14	CD
work_wn6awlddpbeztpigfwaxuan4au	7	13	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	7	14	reporting	report	VBG
work_wn6awlddpbeztpigfwaxuan4au	7	15	severe	severe	JJ
work_wn6awlddpbeztpigfwaxuan4au	7	16	disease	disease	NN
work_wn6awlddpbeztpigfwaxuan4au	7	17	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	8	1	The	the	DT
work_wn6awlddpbeztpigfwaxuan4au	8	2	patient	patient	NN
work_wn6awlddpbeztpigfwaxuan4au	8	3	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	8	4	reported	report	VBN
work_wn6awlddpbeztpigfwaxuan4au	8	5	mean	mean	JJ
work_wn6awlddpbeztpigfwaxuan4au	8	6	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	8	7	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	8	8	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	8	9	morning	morning	NN
work_wn6awlddpbeztpigfwaxuan4au	8	10	stiffness	stiffness	JJ
work_wn6awlddpbeztpigfwaxuan4au	8	11	6.6	6.6	CD
work_wn6awlddpbeztpigfwaxuan4au	8	12	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	8	13	fatigue	fatigue	NN
work_wn6awlddpbeztpigfwaxuan4au	8	14	6.8	6.8	CD
work_wn6awlddpbeztpigfwaxuan4au	8	15	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	8	16	pain	pain	VB
work_wn6awlddpbeztpigfwaxuan4au	8	17	6.5	6.5	CD
work_wn6awlddpbeztpigfwaxuan4au	8	18	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	8	19	HAQ	HAQ	NNP
work_wn6awlddpbeztpigfwaxuan4au	8	20	1.6	1.6	CD
work_wn6awlddpbeztpigfwaxuan4au	8	21	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	8	22	MCS	MCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	8	23	43.9	43.9	CD
work_wn6awlddpbeztpigfwaxuan4au	8	24	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	8	25	PCS	PCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	8	26	36.4	36.4	CD
work_wn6awlddpbeztpigfwaxuan4au	8	27	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	9	1	Patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	9	2	reported	report	VBD
work_wn6awlddpbeztpigfwaxuan4au	9	3	61.0	61.0	CD
work_wn6awlddpbeztpigfwaxuan4au	9	4	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	9	5	work	work	NN
work_wn6awlddpbeztpigfwaxuan4au	9	6	impairment	impairment	NN
work_wn6awlddpbeztpigfwaxuan4au	9	7	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	9	8	59.2	59.2	CD
work_wn6awlddpbeztpigfwaxuan4au	9	9	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	9	10	impairments	impairment	NNS
work_wn6awlddpbeztpigfwaxuan4au	9	11	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	9	12	daily	daily	JJ
work_wn6awlddpbeztpigfwaxuan4au	9	13	activity	activity	NN
work_wn6awlddpbeztpigfwaxuan4au	9	14	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	10	1	Patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	10	2	who	who	WP
work_wn6awlddpbeztpigfwaxuan4au	10	3	had	have	VBD
work_wn6awlddpbeztpigfwaxuan4au	10	4	discontinued	discontinue	VBN
work_wn6awlddpbeztpigfwaxuan4au	10	5	SC	SC	NNP
work_wn6awlddpbeztpigfwaxuan4au	10	6	biologic	biologic	NN
work_wn6awlddpbeztpigfwaxuan4au	10	7	therapy	therapy	NN
work_wn6awlddpbeztpigfwaxuan4au	10	8	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	10	9	N	n	NN
work_wn6awlddpbeztpigfwaxuan4au	10	10	124	124	CD
work_wn6awlddpbeztpigfwaxuan4au	10	11	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	10	12	32.1	32.1	CD
work_wn6awlddpbeztpigfwaxuan4au	10	13	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	10	14	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	10	15	reported	report	VBD
work_wn6awlddpbeztpigfwaxuan4au	10	16	signifi	signifi	NN
work_wn6awlddpbeztpigfwaxuan4au	10	17	cantly	cantly	RB
work_wn6awlddpbeztpigfwaxuan4au	10	18	worse	bad	JJR
work_wn6awlddpbeztpigfwaxuan4au	10	19	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	10	20	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	10	21	morning	morning	NN
work_wn6awlddpbeztpigfwaxuan4au	10	22	stiffness	stiffness	NN
work_wn6awlddpbeztpigfwaxuan4au	10	23	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	10	24	fatigue	fatigue	NN
work_wn6awlddpbeztpigfwaxuan4au	10	25	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	10	26	pain	pain	NN
work_wn6awlddpbeztpigfwaxuan4au	10	27	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	10	28	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	10	29	PCS	PCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	10	30	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	10	31	all	all	DT
work_wn6awlddpbeztpigfwaxuan4au	10	32	P	p	NN
work_wn6awlddpbeztpigfwaxuan4au	10	33	0.05	0.05	CD
work_wn6awlddpbeztpigfwaxuan4au	10	34	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	10	35	versus	versus	IN
work_wn6awlddpbeztpigfwaxuan4au	10	36	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	10	37	currently	currently	RB
work_wn6awlddpbeztpigfwaxuan4au	10	38	treated	treat	VBN
work_wn6awlddpbeztpigfwaxuan4au	10	39	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	10	40	SC	SC	NNP
work_wn6awlddpbeztpigfwaxuan4au	10	41	biologics	biologic	NNS
work_wn6awlddpbeztpigfwaxuan4au	10	42	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	10	43	N	N	NNP
work_wn6awlddpbeztpigfwaxuan4au	10	44	262	262	CD
work_wn6awlddpbeztpigfwaxuan4au	10	45	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	10	46	67.9	67.9	CD
work_wn6awlddpbeztpigfwaxuan4au	10	47	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	10	48	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	10	49	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	11	1	Patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	11	2	who	who	WP
work_wn6awlddpbeztpigfwaxuan4au	11	3	discontinued	discontinue	VBD
work_wn6awlddpbeztpigfwaxuan4au	11	4	therapy	therapy	NN
work_wn6awlddpbeztpigfwaxuan4au	11	5	had	have	VBD
work_wn6awlddpbeztpigfwaxuan4au	11	6	more	more	JJR
work_wn6awlddpbeztpigfwaxuan4au	11	7	work	work	NN
work_wn6awlddpbeztpigfwaxuan4au	11	8	/	/	SYM
work_wn6awlddpbeztpigfwaxuan4au	11	9	activity	activity	NN
work_wn6awlddpbeztpigfwaxuan4au	11	10	loss	loss	NN
work_wn6awlddpbeztpigfwaxuan4au	11	11	;	;	:
work_wn6awlddpbeztpigfwaxuan4au	11	12	only	only	JJ
work_wn6awlddpbeztpigfwaxuan4au	11	13	activity	activity	NN
work_wn6awlddpbeztpigfwaxuan4au	11	14	impair-	impair-	NNS
work_wn6awlddpbeztpigfwaxuan4au	11	15	ment	ment	JJ
work_wn6awlddpbeztpigfwaxuan4au	11	16	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	11	17	statistically	statistically	RB
work_wn6awlddpbeztpigfwaxuan4au	11	18	signifi	signifi	NN
work_wn6awlddpbeztpigfwaxuan4au	11	19	ca	can	MD
work_wn6awlddpbeztpigfwaxuan4au	11	20	nt	not	RB
work_wn6awlddpbeztpigfwaxuan4au	11	21	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	11	22	P	p	NN
work_wn6awlddpbeztpigfwaxuan4au	11	23	0.05	0.05	CD
work_wn6awlddpbeztpigfwaxuan4au	11	24	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	11	25	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	12	1	There	there	EX
work_wn6awlddpbeztpigfwaxuan4au	12	2	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	12	3	no	no	DT
work_wn6awlddpbeztpigfwaxuan4au	12	4	signifi	signifi	NN
work_wn6awlddpbeztpigfwaxuan4au	12	5	ca	can	MD
work_wn6awlddpbeztpigfwaxuan4au	12	6	nt	not	RB
work_wn6awlddpbeztpigfwaxuan4au	12	7	difference	difference	VB
work_wn6awlddpbeztpigfwaxuan4au	12	8	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	12	9	HAQ	HAQ	NNP
work_wn6awlddpbeztpigfwaxuan4au	12	10	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	12	11	between	between	IN
work_wn6awlddpbeztpigfwaxuan4au	12	12	groups	group	NNS
work_wn6awlddpbeztpigfwaxuan4au	12	13	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	13	1	CONCLUSIONS	conclusion	NNS
work_wn6awlddpbeztpigfwaxuan4au	13	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	13	3	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	13	4	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	13	5	using	use	VBG
work_wn6awlddpbeztpigfwaxuan4au	13	6	current	current	JJ
work_wn6awlddpbeztpigfwaxuan4au	13	7	SC	SC	NNP
work_wn6awlddpbeztpigfwaxuan4au	13	8	biolog-	biolog-	JJ
work_wn6awlddpbeztpigfwaxuan4au	13	9	ics	ic	NNS
work_wn6awlddpbeztpigfwaxuan4au	13	10	still	still	RB
work_wn6awlddpbeztpigfwaxuan4au	13	11	suffer	suffer	VB
work_wn6awlddpbeztpigfwaxuan4au	13	12	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	13	13	serious	serious	JJ
work_wn6awlddpbeztpigfwaxuan4au	13	14	impairments	impairment	NNS
work_wn6awlddpbeztpigfwaxuan4au	13	15	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	13	16	symptoms	symptom	NNS
work_wn6awlddpbeztpigfwaxuan4au	13	17	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	13	18	functional	functional	JJ
work_wn6awlddpbeztpigfwaxuan4au	13	19	status	status	NN
work_wn6awlddpbeztpigfwaxuan4au	13	20	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	13	21	QoL	qol	NN
work_wn6awlddpbeztpigfwaxuan4au	13	22	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	13	23	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	13	24	work	work	NN
work_wn6awlddpbeztpigfwaxuan4au	13	25	/	/	SYM
work_wn6awlddpbeztpigfwaxuan4au	13	26	productivity	productivity	NN
work_wn6awlddpbeztpigfwaxuan4au	13	27	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	14	1	However	however	RB
work_wn6awlddpbeztpigfwaxuan4au	14	2	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	14	3	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	14	4	who	who	WP
work_wn6awlddpbeztpigfwaxuan4au	14	5	discontinued	discontinue	VBD
work_wn6awlddpbeztpigfwaxuan4au	14	6	SC	SC	NNP
work_wn6awlddpbeztpigfwaxuan4au	14	7	biologic	biologic	NN
work_wn6awlddpbeztpigfwaxuan4au	14	8	therapy	therapy	NN
work_wn6awlddpbeztpigfwaxuan4au	14	9	have	have	VBP
work_wn6awlddpbeztpigfwaxuan4au	14	10	sig-	sig-	RB
work_wn6awlddpbeztpigfwaxuan4au	14	11	nifi	nifi	NN
work_wn6awlddpbeztpigfwaxuan4au	14	12	cantly	cantly	RB
work_wn6awlddpbeztpigfwaxuan4au	14	13	worse	bad	JJR
work_wn6awlddpbeztpigfwaxuan4au	14	14	symptom	symptom	NN
work_wn6awlddpbeztpigfwaxuan4au	14	15	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	14	16	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	14	17	physical	physical	JJ
work_wn6awlddpbeztpigfwaxuan4au	14	18	functioning	functioning	NN
work_wn6awlddpbeztpigfwaxuan4au	14	19	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	14	20	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	14	21	activity	activity	NN
work_wn6awlddpbeztpigfwaxuan4au	14	22	impairment	impairment	NN
work_wn6awlddpbeztpigfwaxuan4au	14	23	com-	com-	NN
work_wn6awlddpbeztpigfwaxuan4au	14	24	pared	pare	VBD
work_wn6awlddpbeztpigfwaxuan4au	14	25	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	14	26	those	those	DT
work_wn6awlddpbeztpigfwaxuan4au	14	27	currently	currently	RB
work_wn6awlddpbeztpigfwaxuan4au	14	28	being	be	VBG
work_wn6awlddpbeztpigfwaxuan4au	14	29	treated	treat	VBN
work_wn6awlddpbeztpigfwaxuan4au	14	30	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	15	1	Both	both	DT
work_wn6awlddpbeztpigfwaxuan4au	15	2	fi	fi	IN
work_wn6awlddpbeztpigfwaxuan4au	15	3	ndings	nding	NNS
work_wn6awlddpbeztpigfwaxuan4au	15	4	indicate	indicate	VBP
work_wn6awlddpbeztpigfwaxuan4au	15	5	there	there	EX
work_wn6awlddpbeztpigfwaxuan4au	15	6	is	be	VBZ
work_wn6awlddpbeztpigfwaxuan4au	15	7	still	still	RB
work_wn6awlddpbeztpigfwaxuan4au	15	8	an	an	DT
work_wn6awlddpbeztpigfwaxuan4au	15	9	unmet	unmet	JJ
work_wn6awlddpbeztpigfwaxuan4au	15	10	medical	medical	JJ
work_wn6awlddpbeztpigfwaxuan4au	15	11	need	need	NN
work_wn6awlddpbeztpigfwaxuan4au	15	12	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	15	13	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	15	14	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	15	15	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	16	1	PMS40	PMS40	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	2	UTILITY	UTILITY	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	3	AND	and	CC
work_wn6awlddpbeztpigfwaxuan4au	16	4	QUALITY	QUALITY	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	5	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	16	6	LIFE	life	NN
work_wn6awlddpbeztpigfwaxuan4au	16	7	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	16	8	PATIENTS	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	16	9	WITH	with	IN
work_wn6awlddpbeztpigfwaxuan4au	16	10	OSTEOARTHRITIS	osteoarthriti	NNS
work_wn6awlddpbeztpigfwaxuan4au	16	11	TREATED	treated	JJ
work_wn6awlddpbeztpigfwaxuan4au	16	12	WITH	with	IN
work_wn6awlddpbeztpigfwaxuan4au	16	13	THE	the	DT
work_wn6awlddpbeztpigfwaxuan4au	16	14	CYCLOOXYGENASE	CYCLOOXYGENASE	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	15	INHIBITING	INHIBITING	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	16	NITRIC	nitric	NN
work_wn6awlddpbeztpigfwaxuan4au	16	17	OXIDE	OXIDE	NNPS
work_wn6awlddpbeztpigfwaxuan4au	16	18	DONATOR	DONATOR	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	19	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	16	20	CINOD	CINOD	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	21	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	16	22	NAPROXCINOD	NAPROXCINOD	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	23	Jonsson	Jonsson	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	24	B1	B1	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	25	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	26	Pfi	Pfi	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	27	ster	ster	NN
work_wn6awlddpbeztpigfwaxuan4au	16	28	P2	P2	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	29	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	30	Holmstrom	Holmstrom	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	31	S3	S3	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	32	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	33	Kobelt	Kobelt	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	34	G4	G4	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	35	1Uppsala	1Uppsala	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	36	University	University	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	37	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	38	Uppsala	Uppsala	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	39	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	40	Sweden	Sweden	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	41	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	42	2NicOx	2nicox	CD
work_wn6awlddpbeztpigfwaxuan4au	16	43	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	44	Sophia	Sophia	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	45	Antipolis	Antipolis	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	46	Cedex	Cedex	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	47	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	48	France	France	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	49	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	50	3NicOx	3nicox	CD
work_wn6awlddpbeztpigfwaxuan4au	16	51	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	52	Sophia	Sophia	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	53	Antipolis	Antipolis	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	54	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	55	France	France	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	56	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	57	4European	4European	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	58	Health	Health	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	59	Economics	Economics	NNPS
work_wn6awlddpbeztpigfwaxuan4au	16	60	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	61	Speracedes	Speracedes	NNPS
work_wn6awlddpbeztpigfwaxuan4au	16	62	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	63	France	France	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	64	OBJECTIVES	OBJECTIVES	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	65	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	16	66	To	to	TO
work_wn6awlddpbeztpigfwaxuan4au	16	67	estimate	estimate	VB
work_wn6awlddpbeztpigfwaxuan4au	16	68	changes	change	NNS
work_wn6awlddpbeztpigfwaxuan4au	16	69	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	16	70	quality	quality	NN
work_wn6awlddpbeztpigfwaxuan4au	16	71	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	16	72	life	life	NN
work_wn6awlddpbeztpigfwaxuan4au	16	73	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	16	74	SF36	SF36	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	75	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	16	76	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	16	77	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	16	78	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	16	79	SF6	SF6	NNP
work_wn6awlddpbeztpigfwaxuan4au	16	80	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	16	81	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	16	82	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	16	83	treated	treat	VBN
work_wn6awlddpbeztpigfwaxuan4au	16	84	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	16	85	naproxcinod	naproxcinod	NN
work_wn6awlddpbeztpigfwaxuan4au	16	86	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	87	naproxen	naproxen	JJ
work_wn6awlddpbeztpigfwaxuan4au	16	88	or	or	CC
work_wn6awlddpbeztpigfwaxuan4au	16	89	placebo	placebo	NN
work_wn6awlddpbeztpigfwaxuan4au	16	90	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	16	91	13	13	CD
work_wn6awlddpbeztpigfwaxuan4au	16	92	weeks	week	NNS
work_wn6awlddpbeztpigfwaxuan4au	16	93	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	16	94	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	16	95	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	16	96	explore	explore	VB
work_wn6awlddpbeztpigfwaxuan4au	16	97	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	16	98	effect	effect	NN
work_wn6awlddpbeztpigfwaxuan4au	16	99	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	16	100	different	different	JJ
work_wn6awlddpbeztpigfwaxuan4au	16	101	disease	disease	NN
work_wn6awlddpbeztpigfwaxuan4au	16	102	measures	measure	NNS
work_wn6awlddpbeztpigfwaxuan4au	16	103	on	on	IN
work_wn6awlddpbeztpigfwaxuan4au	16	104	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	16	105	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	17	1	METHODS	METHODS	NNP
work_wn6awlddpbeztpigfwaxuan4au	17	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	17	3	SF36	SF36	NNP
work_wn6awlddpbeztpigfwaxuan4au	17	4	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	17	5	available	available	JJ
work_wn6awlddpbeztpigfwaxuan4au	17	6	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	17	7	3	3	CD
work_wn6awlddpbeztpigfwaxuan4au	17	8	international	international	JJ
work_wn6awlddpbeztpigfwaxuan4au	17	9	ph	ph	NNP
work_wn6awlddpbeztpigfwaxuan4au	17	10	3	3	CD
work_wn6awlddpbeztpigfwaxuan4au	17	11	clinical	clinical	JJ
work_wn6awlddpbeztpigfwaxuan4au	17	12	trials	trial	NNS
work_wn6awlddpbeztpigfwaxuan4au	17	13	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	17	14	2738	2738	CD
work_wn6awlddpbeztpigfwaxuan4au	17	15	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	17	16	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	17	17	knee	knee	NN
work_wn6awlddpbeztpigfwaxuan4au	17	18	or	or	CC
work_wn6awlddpbeztpigfwaxuan4au	17	19	hip	hip	NN
work_wn6awlddpbeztpigfwaxuan4au	17	20	osteoarthritis	osteoarthritis	NN
work_wn6awlddpbeztpigfwaxuan4au	17	21	comparing	compare	VBG
work_wn6awlddpbeztpigfwaxuan4au	17	22	2	2	CD
work_wn6awlddpbeztpigfwaxuan4au	17	23	doses	dose	NNS
work_wn6awlddpbeztpigfwaxuan4au	17	24	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	17	25	naproxcinod	naproxcinod	NN
work_wn6awlddpbeztpigfwaxuan4au	17	26	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	17	27	375	375	CD
work_wn6awlddpbeztpigfwaxuan4au	17	28	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	17	29	750	750	CD
work_wn6awlddpbeztpigfwaxuan4au	17	30	mg	mg	NNP
work_wn6awlddpbeztpigfwaxuan4au	17	31	bid	bid	NN
work_wn6awlddpbeztpigfwaxuan4au	17	32	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	17	33	to	to	IN
work_wn6awlddpbeztpigfwaxuan4au	17	34	naproxen	naproxen	NNP
work_wn6awlddpbeztpigfwaxuan4au	17	35	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	17	36	500	500	CD
work_wn6awlddpbeztpigfwaxuan4au	17	37	mg	mg	NNP
work_wn6awlddpbeztpigfwaxuan4au	17	38	bid	bid	NN
work_wn6awlddpbeztpigfwaxuan4au	17	39	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	17	40	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	17	41	placebo	placebo	NN
work_wn6awlddpbeztpigfwaxuan4au	17	42	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	18	1	Effi	Effi	NNP
work_wn6awlddpbeztpigfwaxuan4au	18	2	cacy	cacy	NN
work_wn6awlddpbeztpigfwaxuan4au	18	3	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	18	4	based	base	VBN
work_wn6awlddpbeztpigfwaxuan4au	18	5	on	on	IN
work_wn6awlddpbeztpigfwaxuan4au	18	6	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	18	7	pain	pain	NN
work_wn6awlddpbeztpigfwaxuan4au	18	8	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	18	9	function	function	NN
work_wn6awlddpbeztpigfwaxuan4au	18	10	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	18	11	composite	composite	JJ
work_wn6awlddpbeztpigfwaxuan4au	18	12	scales	scale	NNS
work_wn6awlddpbeztpigfwaxuan4au	18	13	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	18	14	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	18	15	WOMAC	WOMAC	NNP
work_wn6awlddpbeztpigfwaxuan4au	18	16	™	™	CD
work_wn6awlddpbeztpigfwaxuan4au	18	17	osteoarthritis	osteoarthritis	JJ
work_wn6awlddpbeztpigfwaxuan4au	18	18	index	index	NN
work_wn6awlddpbeztpigfwaxuan4au	18	19	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	19	1	Co	co	NN
work_wn6awlddpbeztpigfwaxuan4au	19	2	-	-	JJ
work_wn6awlddpbeztpigfwaxuan4au	19	3	morbidity	morbidity	JJ
work_wn6awlddpbeztpigfwaxuan4au	19	4	measures	measure	NNS
work_wn6awlddpbeztpigfwaxuan4au	19	5	included	include	VBD
work_wn6awlddpbeztpigfwaxuan4au	19	6	hypertension	hypertension	NN
work_wn6awlddpbeztpigfwaxuan4au	19	7	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	19	8	HT	HT	NNP
work_wn6awlddpbeztpigfwaxuan4au	19	9	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	19	10	which	which	WDT
work_wn6awlddpbeztpigfwaxuan4au	19	11	increases	increase	VBZ
work_wn6awlddpbeztpigfwaxuan4au	19	12	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	19	13	NSAID	NSAID	NNP
work_wn6awlddpbeztpigfwaxuan4au	19	14	therapy	therapy	NN
work_wn6awlddpbeztpigfwaxuan4au	19	15	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	19	16	body	body	NN
work_wn6awlddpbeztpigfwaxuan4au	19	17	mass	mass	NN
work_wn6awlddpbeztpigfwaxuan4au	19	18	index	index	NN
work_wn6awlddpbeztpigfwaxuan4au	19	19	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	19	20	BMI	BMI	NNP
work_wn6awlddpbeztpigfwaxuan4au	19	21	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	19	22	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	19	23	diabetes	diabete	NNS
work_wn6awlddpbeztpigfwaxuan4au	19	24	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	20	1	Changes	change	NNS
work_wn6awlddpbeztpigfwaxuan4au	20	2	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	20	3	SF6	SF6	NNP
work_wn6awlddpbeztpigfwaxuan4au	20	4	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	20	5	individual	individual	JJ
work_wn6awlddpbeztpigfwaxuan4au	20	6	SF36	SF36	NNP
work_wn6awlddpbeztpigfwaxuan4au	20	7	domains	domain	NNS
work_wn6awlddpbeztpigfwaxuan4au	20	8	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	20	9	compared	compare	VBN
work_wn6awlddpbeztpigfwaxuan4au	20	10	between	between	IN
work_wn6awlddpbeztpigfwaxuan4au	20	11	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	20	12	groups	group	NNS
work_wn6awlddpbeztpigfwaxuan4au	20	13	using	use	VBG
work_wn6awlddpbeztpigfwaxuan4au	20	14	ANOVA	ANOVA	NNP
work_wn6awlddpbeztpigfwaxuan4au	20	15	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	20	16	Dunett	Dunett	NNP
work_wn6awlddpbeztpigfwaxuan4au	20	17	’s	’s	NNP
work_wn6awlddpbeztpigfwaxuan4au	20	18	2-sided	2-sided	CD
work_wn6awlddpbeztpigfwaxuan4au	20	19	test	test	NN
work_wn6awlddpbeztpigfwaxuan4au	20	20	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	21	1	The	the	DT
work_wn6awlddpbeztpigfwaxuan4au	21	2	effect	effect	NN
work_wn6awlddpbeztpigfwaxuan4au	21	3	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	21	4	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	21	5	WOMAC	WOMAC	NNP
work_wn6awlddpbeztpigfwaxuan4au	21	6	™	™	NN
work_wn6awlddpbeztpigfwaxuan4au	21	7	indices	index	NNS
work_wn6awlddpbeztpigfwaxuan4au	21	8	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	21	9	BP	BP	NNP
work_wn6awlddpbeztpigfwaxuan4au	21	10	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	21	11	BMI	BMI	NNP
work_wn6awlddpbeztpigfwaxuan4au	21	12	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	21	13	diabetes	diabete	NNS
work_wn6awlddpbeztpigfwaxuan4au	21	14	on	on	IN
work_wn6awlddpbeztpigfwaxuan4au	21	15	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	21	16	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	21	17	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	21	18	explored	explore	VBN
work_wn6awlddpbeztpigfwaxuan4au	21	19	using	use	VBG
work_wn6awlddpbeztpigfwaxuan4au	21	20	multiple	multiple	JJ
work_wn6awlddpbeztpigfwaxuan4au	21	21	regression	regression	NN
work_wn6awlddpbeztpigfwaxuan4au	21	22	analysis	analysis	NN
work_wn6awlddpbeztpigfwaxuan4au	21	23	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	22	1	RESULTS	RESULTS	NNP
work_wn6awlddpbeztpigfwaxuan4au	22	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	22	3	All	all	DT
work_wn6awlddpbeztpigfwaxuan4au	22	4	SF36	SF36	NNP
work_wn6awlddpbeztpigfwaxuan4au	22	5	subscales	subscale	NNS
work_wn6awlddpbeztpigfwaxuan4au	22	6	except	except	IN
work_wn6awlddpbeztpigfwaxuan4au	22	7	mental	mental	JJ
work_wn6awlddpbeztpigfwaxuan4au	22	8	health	health	NN
work_wn6awlddpbeztpigfwaxuan4au	22	9	as	as	RB
work_wn6awlddpbeztpigfwaxuan4au	22	10	well	well	RB
work_wn6awlddpbeztpigfwaxuan4au	22	11	as	as	IN
work_wn6awlddpbeztpigfwaxuan4au	22	12	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	22	13	changed	change	VBD
work_wn6awlddpbeztpigfwaxuan4au	22	14	signifi	signifi	VBD
work_wn6awlddpbeztpigfwaxuan4au	22	15	cantly	cantly	RB
work_wn6awlddpbeztpigfwaxuan4au	22	16	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	22	17	baseline	baseline	NN
work_wn6awlddpbeztpigfwaxuan4au	22	18	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	22	19	all	all	DT
work_wn6awlddpbeztpigfwaxuan4au	22	20	groups	group	NNS
work_wn6awlddpbeztpigfwaxuan4au	22	21	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	22	22	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	22	23	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	22	24	correlated	correlate	VBN
work_wn6awlddpbeztpigfwaxuan4au	22	25	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	22	26	changes	change	NNS
work_wn6awlddpbeztpigfwaxuan4au	22	27	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	22	28	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	22	29	WOMAC	WOMAC	NNP
work_wn6awlddpbeztpigfwaxuan4au	22	30	™	™	NN
work_wn6awlddpbeztpigfwaxuan4au	22	31	indices	index	NNS
work_wn6awlddpbeztpigfwaxuan4au	22	32	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	22	33	p	p	NNP
work_wn6awlddpbeztpigfwaxuan4au	22	34	0.001	0.001	CD
work_wn6awlddpbeztpigfwaxuan4au	22	35	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	22	36	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	23	1	The	the	DT
work_wn6awlddpbeztpigfwaxuan4au	23	2	change	change	NN
work_wn6awlddpbeztpigfwaxuan4au	23	3	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	23	4	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	23	5	active	active	JJ
work_wn6awlddpbeztpigfwaxuan4au	23	6	groups	group	NNS
work_wn6awlddpbeztpigfwaxuan4au	23	7	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	23	8	signifi	signifi	VBN
work_wn6awlddpbeztpigfwaxuan4au	23	9	cantly	cantly	RB
work_wn6awlddpbeztpigfwaxuan4au	23	10	better	well	RBR
work_wn6awlddpbeztpigfwaxuan4au	23	11	than	than	IN
work_wn6awlddpbeztpigfwaxuan4au	23	12	placebo	placebo	NN
work_wn6awlddpbeztpigfwaxuan4au	23	13	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	23	14	pain	pain	NN
work_wn6awlddpbeztpigfwaxuan4au	23	15	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	23	16	physical	physical	JJ
work_wn6awlddpbeztpigfwaxuan4au	23	17	function	function	NN
work_wn6awlddpbeztpigfwaxuan4au	23	18	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	23	19	0.05	0.05	CD
work_wn6awlddpbeztpigfwaxuan4au	23	20	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	23	21	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	23	22	but	but	CC
work_wn6awlddpbeztpigfwaxuan4au	23	23	not	not	RB
work_wn6awlddpbeztpigfwaxuan4au	23	24	signifi	signifi	VB
work_wn6awlddpbeztpigfwaxuan4au	23	25	cantly	cantly	RB
work_wn6awlddpbeztpigfwaxuan4au	23	26	different	different	JJ
work_wn6awlddpbeztpigfwaxuan4au	23	27	between	between	IN
work_wn6awlddpbeztpigfwaxuan4au	23	28	treatments	treatment	NNS
work_wn6awlddpbeztpigfwaxuan4au	23	29	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	24	1	However	however	RB
work_wn6awlddpbeztpigfwaxuan4au	24	2	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	24	3	absolute	absolute	JJ
work_wn6awlddpbeztpigfwaxuan4au	24	4	changes	change	NNS
work_wn6awlddpbeztpigfwaxuan4au	24	5	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	24	6	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	24	7	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	24	8	pain	pain	NN
work_wn6awlddpbeztpigfwaxuan4au	24	9	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	24	10	physical	physical	JJ
work_wn6awlddpbeztpigfwaxuan4au	24	11	function	function	NN
work_wn6awlddpbeztpigfwaxuan4au	24	12	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	24	13	general	general	JJ
work_wn6awlddpbeztpigfwaxuan4au	24	14	health	health	NN
work_wn6awlddpbeztpigfwaxuan4au	24	15	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	24	16	generally	generally	RB
work_wn6awlddpbeztpigfwaxuan4au	24	17	larger	large	JJR
work_wn6awlddpbeztpigfwaxuan4au	24	18	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	24	19	naproxcinod	naproxcinod	NN
work_wn6awlddpbeztpigfwaxuan4au	24	20	750	750	CD
work_wn6awlddpbeztpigfwaxuan4au	24	21	mg	mg	NNP
work_wn6awlddpbeztpigfwaxuan4au	24	22	than	than	IN
work_wn6awlddpbeztpigfwaxuan4au	24	23	naproxen	naproxen	NNP
work_wn6awlddpbeztpigfwaxuan4au	24	24	500	500	CD
work_wn6awlddpbeztpigfwaxuan4au	24	25	mg	mg	NNP
work_wn6awlddpbeztpigfwaxuan4au	24	26	by	by	IN
work_wn6awlddpbeztpigfwaxuan4au	24	27	around	around	IN
work_wn6awlddpbeztpigfwaxuan4au	24	28	10	10	CD
work_wn6awlddpbeztpigfwaxuan4au	24	29	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	24	30	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	25	1	Utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	25	2	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	25	3	correlated	correlate	VBD
work_wn6awlddpbeztpigfwaxuan4au	25	4	signifi	signifi	VBD
work_wn6awlddpbeztpigfwaxuan4au	25	5	cantly	cantly	RB
work_wn6awlddpbeztpigfwaxuan4au	25	6	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	25	7	WOMAC	WOMAC	NNP
work_wn6awlddpbeztpigfwaxuan4au	25	8	™	™	CD
work_wn6awlddpbeztpigfwaxuan4au	25	9	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	25	10	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	25	11	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	25	12	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	25	13	high	high	JJ
work_wn6awlddpbeztpigfwaxuan4au	25	14	BMI	BMI	NNP
work_wn6awlddpbeztpigfwaxuan4au	25	15	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	25	16	BP	bp	NN
work_wn6awlddpbeztpigfwaxuan4au	25	17	or	or	CC
work_wn6awlddpbeztpigfwaxuan4au	25	18	diabetes	diabetes	NN
work_wn6awlddpbeztpigfwaxuan4au	25	19	had	have	VBD
work_wn6awlddpbeztpigfwaxuan4au	25	20	lower	low	JJR
work_wn6awlddpbeztpigfwaxuan4au	25	21	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	25	22	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	25	23	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	25	24	worse	bad	JJR
work_wn6awlddpbeztpigfwaxuan4au	25	25	WOMAC	WOMAC	NNP
work_wn6awlddpbeztpigfwaxuan4au	25	26	™	™	NNP
work_wn6awlddpbeztpigfwaxuan4au	25	27	indices	index	NNS
work_wn6awlddpbeztpigfwaxuan4au	25	28	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	26	1	Increase	increase	NN
work_wn6awlddpbeztpigfwaxuan4au	26	2	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	26	3	utilities	utility	NNS
work_wn6awlddpbeztpigfwaxuan4au	26	4	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	26	5	larger	large	JJR
work_wn6awlddpbeztpigfwaxuan4au	26	6	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	26	7	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	26	8	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	26	9	750	750	CD
work_wn6awlddpbeztpigfwaxuan4au	26	10	mg	mg	NNP
work_wn6awlddpbeztpigfwaxuan4au	26	11	naproxcinod	naproxcinod	NN
work_wn6awlddpbeztpigfwaxuan4au	26	12	than	than	IN
work_wn6awlddpbeztpigfwaxuan4au	26	13	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	26	14	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	26	15	other	other	JJ
work_wn6awlddpbeztpigfwaxuan4au	26	16	groups	group	NNS
work_wn6awlddpbeztpigfwaxuan4au	26	17	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	27	1	CONCLUSIONS	conclusion	NNS
work_wn6awlddpbeztpigfwaxuan4au	27	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	27	3	The	the	DT
work_wn6awlddpbeztpigfwaxuan4au	27	4	slightly	slightly	RB
work_wn6awlddpbeztpigfwaxuan4au	27	5	larger	large	JJR
work_wn6awlddpbeztpigfwaxuan4au	27	6	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	27	7	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	27	8	quality	quality	NN
work_wn6awlddpbeztpigfwaxuan4au	27	9	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	27	10	life	life	NN
work_wn6awlddpbeztpigfwaxuan4au	27	11	changes	change	VBZ
work_wn6awlddpbeztpigfwaxuan4au	27	12	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	27	13	naprox-	naprox-	NNP
work_wn6awlddpbeztpigfwaxuan4au	27	14	cinod	cinod	NNP
work_wn6awlddpbeztpigfwaxuan4au	27	15	750	750	CD
work_wn6awlddpbeztpigfwaxuan4au	27	16	mg	mg	NNP
work_wn6awlddpbeztpigfwaxuan4au	27	17	despite	despite	IN
work_wn6awlddpbeztpigfwaxuan4au	27	18	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	27	19	similar	similar	JJ
work_wn6awlddpbeztpigfwaxuan4au	27	20	effect	effect	NN
work_wn6awlddpbeztpigfwaxuan4au	27	21	as	as	IN
work_wn6awlddpbeztpigfwaxuan4au	27	22	naproxen	naproxen	JJ
work_wn6awlddpbeztpigfwaxuan4au	27	23	on	on	IN
work_wn6awlddpbeztpigfwaxuan4au	27	24	WOMAC	WOMAC	NNP
work_wn6awlddpbeztpigfwaxuan4au	27	25	™	™	CD
work_wn6awlddpbeztpigfwaxuan4au	27	26	may	may	MD
work_wn6awlddpbeztpigfwaxuan4au	27	27	be	be	VB
work_wn6awlddpbeztpigfwaxuan4au	27	28	explained	explain	VBN
work_wn6awlddpbeztpigfwaxuan4au	27	29	by	by	IN
work_wn6awlddpbeztpigfwaxuan4au	27	30	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	27	31	different	different	JJ
work_wn6awlddpbeztpigfwaxuan4au	27	32	side	side	NN
work_wn6awlddpbeztpigfwaxuan4au	27	33	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	27	34	effect	effect	NN
work_wn6awlddpbeztpigfwaxuan4au	27	35	profi	profi	NNP
work_wn6awlddpbeztpigfwaxuan4au	27	36	le	le	NNP
work_wn6awlddpbeztpigfwaxuan4au	27	37	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	27	38	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	27	39	neutral	neutral	JJ
work_wn6awlddpbeztpigfwaxuan4au	27	40	blood	blood	NN
work_wn6awlddpbeztpigfwaxuan4au	27	41	pressure	pressure	NN
work_wn6awlddpbeztpigfwaxuan4au	27	42	effect	effect	NN
work_wn6awlddpbeztpigfwaxuan4au	27	43	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	28	1	PMS41	PMS41	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	2	AN	an	DT
work_wn6awlddpbeztpigfwaxuan4au	28	3	ASSESSMENT	ASSESSMENT	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	4	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	28	5	SELF	SELF	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	6	REPORTED	report	VBN
work_wn6awlddpbeztpigfwaxuan4au	28	7	OUTCOMES	outcomes	RB
work_wn6awlddpbeztpigfwaxuan4au	28	8	IN	in	IN
work_wn6awlddpbeztpigfwaxuan4au	28	9	A	a	DT
work_wn6awlddpbeztpigfwaxuan4au	28	10	NATIONALLY	nationally	JJ
work_wn6awlddpbeztpigfwaxuan4au	28	11	REPRESENTATIVE	representative	NN
work_wn6awlddpbeztpigfwaxuan4au	28	12	SAMPLE	sample	NN
work_wn6awlddpbeztpigfwaxuan4au	28	13	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	28	14	ELDERLY	elderly	NN
work_wn6awlddpbeztpigfwaxuan4au	28	15	PERSON	person	NN
work_wn6awlddpbeztpigfwaxuan4au	28	16	DIAGNOSED	DIAGNOSED	NNS
work_wn6awlddpbeztpigfwaxuan4au	28	17	WITH	with	IN
work_wn6awlddpbeztpigfwaxuan4au	28	18	RHEUMATOID	RHEUMATOID	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	19	ARTHRITIS	ARTHRITIS	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	20	Rajpura	Rajpura	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	21	JRjp	JRjp	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	22	J	J	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	23	St.	St.	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	24	John	John	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	25	’s	’s	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	26	University	University	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	27	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	28	28	Fresh	Fresh	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	29	Meadows	Meadows	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	30	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	28	31	NY	NY	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	32	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	28	33	USA	USA	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	34	OBJECTIVES	OBJECTIVES	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	35	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	28	36	To	to	TO
work_wn6awlddpbeztpigfwaxuan4au	28	37	utilize	utilize	VB
work_wn6awlddpbeztpigfwaxuan4au	28	38	WebTV	WebTV	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	39	technology	technology	NN
work_wn6awlddpbeztpigfwaxuan4au	28	40	as	as	IN
work_wn6awlddpbeztpigfwaxuan4au	28	41	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	28	42	tool	tool	NN
work_wn6awlddpbeztpigfwaxuan4au	28	43	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	28	44	measure	measure	VB
work_wn6awlddpbeztpigfwaxuan4au	28	45	HRQOL	HRQOL	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	46	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	28	47	elderly	elderly	JJ
work_wn6awlddpbeztpigfwaxuan4au	28	48	persons	person	NNS
work_wn6awlddpbeztpigfwaxuan4au	28	49	having	have	VBG
work_wn6awlddpbeztpigfwaxuan4au	28	50	Rheumatoid	Rheumatoid	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	51	Arthritis	Arthritis	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	52	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	28	53	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	28	54	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	28	55	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	28	56	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	28	57	nationally	nationally	RB
work_wn6awlddpbeztpigfwaxuan4au	28	58	representative	representative	JJ
work_wn6awlddpbeztpigfwaxuan4au	28	59	sample	sample	NN
work_wn6awlddpbeztpigfwaxuan4au	28	60	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	28	61	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	28	62	describe	describe	VB
work_wn6awlddpbeztpigfwaxuan4au	28	63	their	-PRON-	PRP$
work_wn6awlddpbeztpigfwaxuan4au	28	64	socio	socio	JJ
work_wn6awlddpbeztpigfwaxuan4au	28	65	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	28	66	demographic	demographic	JJ
work_wn6awlddpbeztpigfwaxuan4au	28	67	characteristics	characteristic	NNS
work_wn6awlddpbeztpigfwaxuan4au	28	68	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	28	69	medication	medication	NN
work_wn6awlddpbeztpigfwaxuan4au	28	70	use	use	NN
work_wn6awlddpbeztpigfwaxuan4au	28	71	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	28	72	other	other	JJ
work_wn6awlddpbeztpigfwaxuan4au	28	73	treat-	treat-	JJ
work_wn6awlddpbeztpigfwaxuan4au	28	74	ment	ment	JJ
work_wn6awlddpbeztpigfwaxuan4au	28	75	choices	choice	NNS
work_wn6awlddpbeztpigfwaxuan4au	28	76	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	29	1	METHODS	METHODS	NNP
work_wn6awlddpbeztpigfwaxuan4au	29	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	29	3	A	a	DT
work_wn6awlddpbeztpigfwaxuan4au	29	4	cross-	cross-	JJ
work_wn6awlddpbeztpigfwaxuan4au	29	5	sectional	sectional	JJ
work_wn6awlddpbeztpigfwaxuan4au	29	6	online	online	JJ
work_wn6awlddpbeztpigfwaxuan4au	29	7	survey	survey	NN
work_wn6awlddpbeztpigfwaxuan4au	29	8	research	research	NN
work_wn6awlddpbeztpigfwaxuan4au	29	9	design	design	NN
work_wn6awlddpbeztpigfwaxuan4au	29	10	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	30	1	Random	random	JJ
work_wn6awlddpbeztpigfwaxuan4au	30	2	digit	digit	NN
work_wn6awlddpbeztpigfwaxuan4au	30	3	dialing	dialing	NN
work_wn6awlddpbeztpigfwaxuan4au	30	4	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	30	5	RDD	RDD	NNP
work_wn6awlddpbeztpigfwaxuan4au	30	6	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	30	7	survey	survey	NN
work_wn6awlddpbeztpigfwaxuan4au	30	8	procedures	procedure	NNS
work_wn6awlddpbeztpigfwaxuan4au	30	9	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	30	10	used	use	VBN
work_wn6awlddpbeztpigfwaxuan4au	30	11	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	30	12	draw	draw	VB
work_wn6awlddpbeztpigfwaxuan4au	30	13	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	30	14	sample	sample	NN
work_wn6awlddpbeztpigfwaxuan4au	30	15	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	30	16	550	550	CD
work_wn6awlddpbeztpigfwaxuan4au	30	17	elderly	elderly	JJ
work_wn6awlddpbeztpigfwaxuan4au	30	18	arthritic	arthritic	JJ
work_wn6awlddpbeztpigfwaxuan4au	30	19	individuals	individual	NNS
work_wn6awlddpbeztpigfwaxuan4au	30	20	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	30	21	US	US	NNP
work_wn6awlddpbeztpigfwaxuan4au	30	22	households	household	NNS
work_wn6awlddpbeztpigfwaxuan4au	30	23	across	across	IN
work_wn6awlddpbeztpigfwaxuan4au	30	24	44	44	CD
work_wn6awlddpbeztpigfwaxuan4au	30	25	states	state	NNS
work_wn6awlddpbeztpigfwaxuan4au	30	26	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	31	1	A	a	DT
work_wn6awlddpbeztpigfwaxuan4au	31	2	subsample	subsample	NN
work_wn6awlddpbeztpigfwaxuan4au	31	3	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	31	4	79	79	CD
work_wn6awlddpbeztpigfwaxuan4au	31	5	individu-	individu-	NN
work_wn6awlddpbeztpigfwaxuan4au	31	6	als	als	NNP
work_wn6awlddpbeztpigfwaxuan4au	31	7	previously	previously	RB
work_wn6awlddpbeztpigfwaxuan4au	31	8	diagnosed	diagnose	VBN
work_wn6awlddpbeztpigfwaxuan4au	31	9	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	31	10	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	31	11	completed	complete	VBD
work_wn6awlddpbeztpigfwaxuan4au	31	12	SF-36v2	SF-36v2	NNP
work_wn6awlddpbeztpigfwaxuan4au	31	13	survey	survey	NN
work_wn6awlddpbeztpigfwaxuan4au	31	14	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	31	15	as	as	IN
work_wn6awlddpbeztpigfwaxuan4au	31	16	part	part	NN
work_wn6awlddpbeztpigfwaxuan4au	31	17	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	31	18	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	31	19	larger	large	JJR
work_wn6awlddpbeztpigfwaxuan4au	31	20	study	study	NN
work_wn6awlddpbeztpigfwaxuan4au	31	21	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	32	1	Eight	eight	CD
work_wn6awlddpbeztpigfwaxuan4au	32	2	SF-36	SF-36	NNP
work_wn6awlddpbeztpigfwaxuan4au	32	3	domain	domain	NN
work_wn6awlddpbeztpigfwaxuan4au	32	4	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	32	5	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	32	6	Physical	Physical	NNP
work_wn6awlddpbeztpigfwaxuan4au	32	7	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	32	8	Mental	Mental	NNP
work_wn6awlddpbeztpigfwaxuan4au	32	9	Component	Component	NNP
work_wn6awlddpbeztpigfwaxuan4au	32	10	Summary	Summary	NNP
work_wn6awlddpbeztpigfwaxuan4au	32	11	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	32	12	PCS	PCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	32	13	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	32	14	MCS	MCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	32	15	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	32	16	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	32	17	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	32	18	computed	compute	VBN
work_wn6awlddpbeztpigfwaxuan4au	32	19	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	32	20	compared	compare	VBN
work_wn6awlddpbeztpigfwaxuan4au	32	21	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	32	22	cross	cross	JJ
work_wn6awlddpbeztpigfwaxuan4au	32	23	-	-	JJ
work_wn6awlddpbeztpigfwaxuan4au	32	24	sectional	sectional	JJ
work_wn6awlddpbeztpigfwaxuan4au	32	25	norms	norm	NNS
work_wn6awlddpbeztpigfwaxuan4au	32	26	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	32	27	general	general	JJ
work_wn6awlddpbeztpigfwaxuan4au	32	28	US	US	NNP
work_wn6awlddpbeztpigfwaxuan4au	32	29	population	population	NN
work_wn6awlddpbeztpigfwaxuan4au	32	30	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	33	1	RESULTS	RESULTS	NNP
work_wn6awlddpbeztpigfwaxuan4au	33	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	33	3	Compared	compare	VBN
work_wn6awlddpbeztpigfwaxuan4au	33	4	to	to	IN
work_wn6awlddpbeztpigfwaxuan4au	33	5	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	33	6	general	general	JJ
work_wn6awlddpbeztpigfwaxuan4au	33	7	population	population	NN
work_wn6awlddpbeztpigfwaxuan4au	33	8	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	33	9	our	-PRON-	PRP$
work_wn6awlddpbeztpigfwaxuan4au	33	10	study	study	NN
work_wn6awlddpbeztpigfwaxuan4au	33	11	sample	sample	NN
work_wn6awlddpbeztpigfwaxuan4au	33	12	per-	per-	NN
work_wn6awlddpbeztpigfwaxuan4au	33	13	formed	form	VBD
work_wn6awlddpbeztpigfwaxuan4au	33	14	poorly	poorly	RB
work_wn6awlddpbeztpigfwaxuan4au	33	15	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	33	16	respect	respect	NN
work_wn6awlddpbeztpigfwaxuan4au	33	17	to	to	IN
work_wn6awlddpbeztpigfwaxuan4au	33	18	all	all	PDT
work_wn6awlddpbeztpigfwaxuan4au	33	19	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	33	20	SF-36	SF-36	NNP
work_wn6awlddpbeztpigfwaxuan4au	33	21	domains	domain	NNS
work_wn6awlddpbeztpigfwaxuan4au	33	22	except	except	IN
work_wn6awlddpbeztpigfwaxuan4au	33	23	mental	mental	JJ
work_wn6awlddpbeztpigfwaxuan4au	33	24	health	health	NN
work_wn6awlddpbeztpigfwaxuan4au	33	25	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	33	26	MH	MH	NNP
work_wn6awlddpbeztpigfwaxuan4au	33	27	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	33	28	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	33	29	social	social	JJ
work_wn6awlddpbeztpigfwaxuan4au	33	30	functioning	functioning	NN
work_wn6awlddpbeztpigfwaxuan4au	33	31	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	33	32	SF	SF	NNP
work_wn6awlddpbeztpigfwaxuan4au	33	33	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	33	34	domains	domain	NNS
work_wn6awlddpbeztpigfwaxuan4au	33	35	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	34	1	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	34	2	is	be	VBZ
work_wn6awlddpbeztpigfwaxuan4au	34	3	more	more	RBR
work_wn6awlddpbeztpigfwaxuan4au	34	4	prevalent	prevalent	JJ
work_wn6awlddpbeztpigfwaxuan4au	34	5	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	34	6	whites	white	NNS
work_wn6awlddpbeztpigfwaxuan4au	34	7	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	34	8	96	96	CD
work_wn6awlddpbeztpigfwaxuan4au	34	9	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	34	10	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	34	11	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	34	12	males	male	NNS
work_wn6awlddpbeztpigfwaxuan4au	34	13	reported	report	VBD
work_wn6awlddpbeztpigfwaxuan4au	34	14	higher	high	JJR
work_wn6awlddpbeztpigfwaxuan4au	34	15	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	34	16	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	34	17	all	all	PDT
work_wn6awlddpbeztpigfwaxuan4au	34	18	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	34	19	eight	eight	CD
work_wn6awlddpbeztpigfwaxuan4au	34	20	SF-36	SF-36	NNP
work_wn6awlddpbeztpigfwaxuan4au	34	21	domains	domain	NNS
work_wn6awlddpbeztpigfwaxuan4au	34	22	than	than	IN
work_wn6awlddpbeztpigfwaxuan4au	34	23	females	female	NNS
work_wn6awlddpbeztpigfwaxuan4au	34	24	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	35	1	About	about	RB
work_wn6awlddpbeztpigfwaxuan4au	35	2	92	92	CD
work_wn6awlddpbeztpigfwaxuan4au	35	3	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	35	4	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	35	5	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	35	6	sample	sample	NN
work_wn6awlddpbeztpigfwaxuan4au	35	7	reported	report	VBD
work_wn6awlddpbeztpigfwaxuan4au	35	8	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	35	9	use	use	NN
work_wn6awlddpbeztpigfwaxuan4au	35	10	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	35	11	at	at	RB
work_wn6awlddpbeztpigfwaxuan4au	35	12	least	least	RBS
work_wn6awlddpbeztpigfwaxuan4au	35	13	one	one	CD
work_wn6awlddpbeztpigfwaxuan4au	35	14	available	available	JJ
work_wn6awlddpbeztpigfwaxuan4au	35	15	OTC	OTC	NNP
work_wn6awlddpbeztpigfwaxuan4au	35	16	arthritic	arthritic	JJ
work_wn6awlddpbeztpigfwaxuan4au	35	17	medication	medication	NN
work_wn6awlddpbeztpigfwaxuan4au	35	18	;	;	:
work_wn6awlddpbeztpigfwaxuan4au	35	19	58	58	CD
work_wn6awlddpbeztpigfwaxuan4au	35	20	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	35	21	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	35	22	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	35	23	sample	sample	NN
work_wn6awlddpbeztpigfwaxuan4au	35	24	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	35	25	taking	take	VBG
work_wn6awlddpbeztpigfwaxuan4au	35	26	prescription	prescription	NN
work_wn6awlddpbeztpigfwaxuan4au	35	27	drugs	drug	NNS
work_wn6awlddpbeztpigfwaxuan4au	35	28	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	35	29	while	while	IN
work_wn6awlddpbeztpigfwaxuan4au	35	30	about	about	RB
work_wn6awlddpbeztpigfwaxuan4au	35	31	53	53	CD
work_wn6awlddpbeztpigfwaxuan4au	35	32	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	35	33	reported	report	VBN
work_wn6awlddpbeztpigfwaxuan4au	35	34	having	have	VBG
work_wn6awlddpbeztpigfwaxuan4au	35	35	used	use	VBN
work_wn6awlddpbeztpigfwaxuan4au	35	36	natural	natural	JJ
work_wn6awlddpbeztpigfwaxuan4au	35	37	/	/	SYM
work_wn6awlddpbeztpigfwaxuan4au	35	38	herbal	herbal	JJ
work_wn6awlddpbeztpigfwaxuan4au	35	39	remedies	remedy	NNS
work_wn6awlddpbeztpigfwaxuan4au	35	40	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	35	41	arthritis	arthritis	NN
work_wn6awlddpbeztpigfwaxuan4au	35	42	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	36	1	A	a	DT
work_wn6awlddpbeztpigfwaxuan4au	36	2	signifi	signifi	NN
work_wn6awlddpbeztpigfwaxuan4au	36	3	ca	can	MD
work_wn6awlddpbeztpigfwaxuan4au	36	4	nt	not	RB
work_wn6awlddpbeztpigfwaxuan4au	36	5	difference	difference	VB
work_wn6awlddpbeztpigfwaxuan4au	36	6	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	36	7	p	p	NNP
work_wn6awlddpbeztpigfwaxuan4au	36	8	0.003	0.003	CD
work_wn6awlddpbeztpigfwaxuan4au	36	9	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	36	10	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	36	11	found	find	VBN
work_wn6awlddpbeztpigfwaxuan4au	36	12	between	between	IN
work_wn6awlddpbeztpigfwaxuan4au	36	13	males	male	NNS
work_wn6awlddpbeztpigfwaxuan4au	36	14	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	36	15	females	female	NNS
work_wn6awlddpbeztpigfwaxuan4au	36	16	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	36	17	respect	respect	NN
work_wn6awlddpbeztpigfwaxuan4au	36	18	to	to	IN
work_wn6awlddpbeztpigfwaxuan4au	36	19	only	only	RB
work_wn6awlddpbeztpigfwaxuan4au	36	20	PCS	PCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	36	21	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	36	22	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	37	1	Age	age	NN
work_wn6awlddpbeztpigfwaxuan4au	37	2	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	37	3	found	find	VBN
work_wn6awlddpbeztpigfwaxuan4au	37	4	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	37	5	correlate	correlate	VB
work_wn6awlddpbeztpigfwaxuan4au	37	6	negatively	negatively	RB
work_wn6awlddpbeztpigfwaxuan4au	37	7	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	37	8	p	p	NNP
work_wn6awlddpbeztpigfwaxuan4au	37	9	0.005	0.005	CD
work_wn6awlddpbeztpigfwaxuan4au	37	10	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	37	11	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	37	12	PCS	PCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	37	13	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	37	14	MCS	MCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	37	15	summary	summary	NN
work_wn6awlddpbeztpigfwaxuan4au	37	16	measures	measure	NNS
work_wn6awlddpbeztpigfwaxuan4au	37	17	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	37	18	particularly	particularly	RB
work_wn6awlddpbeztpigfwaxuan4au	37	19	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	37	20	indi-	indi-	NN
work_wn6awlddpbeztpigfwaxuan4au	37	21	viduals	vidual	NNS
work_wn6awlddpbeztpigfwaxuan4au	37	22	70	70	CD
work_wn6awlddpbeztpigfwaxuan4au	37	23	years	year	NNS
work_wn6awlddpbeztpigfwaxuan4au	37	24	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	37	25	older	old	JJR
work_wn6awlddpbeztpigfwaxuan4au	37	26	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	38	1	CONCLUSIONS	conclusion	NNS
work_wn6awlddpbeztpigfwaxuan4au	38	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	38	3	WebTV	WebTV	NNP
work_wn6awlddpbeztpigfwaxuan4au	38	4	is	be	VBZ
work_wn6awlddpbeztpigfwaxuan4au	38	5	an	an	DT
work_wn6awlddpbeztpigfwaxuan4au	38	6	effective	effective	JJ
work_wn6awlddpbeztpigfwaxuan4au	38	7	survey	survey	NN
work_wn6awlddpbeztpigfwaxuan4au	38	8	administra-	administra-	NNS
work_wn6awlddpbeztpigfwaxuan4au	38	9	tion	tion	NN
work_wn6awlddpbeztpigfwaxuan4au	38	10	tool	tool	NN
work_wn6awlddpbeztpigfwaxuan4au	38	11	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	38	12	measuring	measure	VBG
work_wn6awlddpbeztpigfwaxuan4au	38	13	HRQOL	HRQOL	NNP
work_wn6awlddpbeztpigfwaxuan4au	38	14	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	39	1	As	as	IN
work_wn6awlddpbeztpigfwaxuan4au	39	2	expected	expect	VBN
work_wn6awlddpbeztpigfwaxuan4au	39	3	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	39	4	elderly	elderly	JJ
work_wn6awlddpbeztpigfwaxuan4au	39	5	perform	perform	NN
work_wn6awlddpbeztpigfwaxuan4au	39	6	poorly	poorly	RB
work_wn6awlddpbeztpigfwaxuan4au	39	7	on	on	IN
work_wn6awlddpbeztpigfwaxuan4au	39	8	three	three	CD
work_wn6awlddpbeztpigfwaxuan4au	39	9	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	39	10	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	39	11	SF-36	SF-36	NNP
work_wn6awlddpbeztpigfwaxuan4au	39	12	domains	domain	NNS
work_wn6awlddpbeztpigfwaxuan4au	39	13	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	39	14	PF	PF	NNP
work_wn6awlddpbeztpigfwaxuan4au	39	15	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	39	16	RP	RP	NNP
work_wn6awlddpbeztpigfwaxuan4au	39	17	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	39	18	BP	BP	NNP
work_wn6awlddpbeztpigfwaxuan4au	39	19	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	39	20	having	have	VBG
work_wn6awlddpbeztpigfwaxuan4au	39	21	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	39	22	most	most	RBS
work_wn6awlddpbeztpigfwaxuan4au	39	23	physical	physical	JJ
work_wn6awlddpbeztpigfwaxuan4au	39	24	factor	factor	NN
work_wn6awlddpbeztpigfwaxuan4au	39	25	content	content	NN
work_wn6awlddpbeztpigfwaxuan4au	39	26	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	40	1	Prescription	prescription	NN
work_wn6awlddpbeztpigfwaxuan4au	40	2	drug	drug	NN
work_wn6awlddpbeztpigfwaxuan4au	40	3	use	use	NN
work_wn6awlddpbeztpigfwaxuan4au	40	4	is	be	VBZ
work_wn6awlddpbeztpigfwaxuan4au	40	5	fairly	fairly	RB
work_wn6awlddpbeztpigfwaxuan4au	40	6	prevalent	prevalent	JJ
work_wn6awlddpbeztpigfwaxuan4au	40	7	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	40	8	use	use	NN
work_wn6awlddpbeztpigfwaxuan4au	40	9	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	40	10	OTC	OTC	NNP
work_wn6awlddpbeztpigfwaxuan4au	40	11	medications	medication	NNS
work_wn6awlddpbeztpigfwaxuan4au	40	12	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	40	13	other	other	JJ
work_wn6awlddpbeztpigfwaxuan4au	40	14	forms	form	NNS
work_wn6awlddpbeztpigfwaxuan4au	40	15	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	40	16	treatment	treatment	NN
work_wn6awlddpbeztpigfwaxuan4au	40	17	is	be	VBZ
work_wn6awlddpbeztpigfwaxuan4au	40	18	popular	popular	JJ
work_wn6awlddpbeztpigfwaxuan4au	40	19	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	40	20	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	40	21	population	population	NN
work_wn6awlddpbeztpigfwaxuan4au	40	22	under	under	IN
work_wn6awlddpbeztpigfwaxuan4au	40	23	study	study	NN
work_wn6awlddpbeztpigfwaxuan4au	40	24	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	41	1	PMS42	pms42	VB
work_wn6awlddpbeztpigfwaxuan4au	41	2	THE	the	DT
work_wn6awlddpbeztpigfwaxuan4au	41	3	EFFECT	EFFECT	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	4	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	41	5	LIFESTYLE	LIFESTYLE	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	6	CHOICES	choice	NNS
work_wn6awlddpbeztpigfwaxuan4au	41	7	ON	on	IN
work_wn6awlddpbeztpigfwaxuan4au	41	8	THE	the	DT
work_wn6awlddpbeztpigfwaxuan4au	41	9	RISK	risk	NN
work_wn6awlddpbeztpigfwaxuan4au	41	10	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	41	11	IMPAIRMENT	IMPAIRMENT	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	12	IN	in	IN
work_wn6awlddpbeztpigfwaxuan4au	41	13	RHEUMATOID	RHEUMATOID	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	14	ARTHRITIS	arthritis	NN
work_wn6awlddpbeztpigfwaxuan4au	41	15	PATIENTS	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	41	16	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	41	17	AN	an	DT
work_wn6awlddpbeztpigfwaxuan4au	41	18	ANALYSIS	analysis	NN
work_wn6awlddpbeztpigfwaxuan4au	41	19	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	41	20	AEROBIC	aerobic	JJ
work_wn6awlddpbeztpigfwaxuan4au	41	21	EXERCISE	exercise	NN
work_wn6awlddpbeztpigfwaxuan4au	41	22	AND	and	CC
work_wn6awlddpbeztpigfwaxuan4au	41	23	CIGARETTE	cigarette	NN
work_wn6awlddpbeztpigfwaxuan4au	41	24	SMOKING	smoking	NN
work_wn6awlddpbeztpigfwaxuan4au	41	25	Shah	Shah	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	26	A1	A1	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	27	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	28	Plumb	Plumb	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	29	J1	J1	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	30	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	31	Brawer	Brawer	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	32	R1	R1	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	33	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	34	Tang	Tang	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	35	B2	b2	NN
work_wn6awlddpbeztpigfwaxuan4au	41	36	1Thomas	1Thomas	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	37	Jefferson	Jefferson	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	38	University	University	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	39	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	40	Philadelphia	Philadelphia	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	41	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	42	PA	PA	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	43	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	44	USA	USA	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	45	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	46	2Centocor	2Centocor	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	47	Ortho	Ortho	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	48	Biotech	Biotech	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	49	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	50	Inc	Inc	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	51	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	52	Horsham	Horsham	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	53	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	54	PA	PA	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	55	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	41	56	USA	USA	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	57	OBJECTIVES	OBJECTIVES	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	58	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	41	59	Through	through	IN
work_wn6awlddpbeztpigfwaxuan4au	41	60	data	datum	NNS
work_wn6awlddpbeztpigfwaxuan4au	41	61	analysis	analysis	NN
work_wn6awlddpbeztpigfwaxuan4au	41	62	we	-PRON-	PRP
work_wn6awlddpbeztpigfwaxuan4au	41	63	will	will	MD
work_wn6awlddpbeztpigfwaxuan4au	41	64	examine	examine	VB
work_wn6awlddpbeztpigfwaxuan4au	41	65	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	41	66	identify	identify	VB
work_wn6awlddpbeztpigfwaxuan4au	41	67	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	41	68	lifestyle	lifestyle	NN
work_wn6awlddpbeztpigfwaxuan4au	41	69	factors	factor	NNS
work_wn6awlddpbeztpigfwaxuan4au	41	70	that	that	WDT
work_wn6awlddpbeztpigfwaxuan4au	41	71	impact	impact	VBP
work_wn6awlddpbeztpigfwaxuan4au	41	72	clinical	clinical	JJ
work_wn6awlddpbeztpigfwaxuan4au	41	73	outcomes	outcome	NNS
work_wn6awlddpbeztpigfwaxuan4au	41	74	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	41	75	Rheumatoid	Rheumatoid	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	76	Arthritis	Arthritis	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	77	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	41	78	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	41	79	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	41	80	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	41	81	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	42	1	METHODS	methods	JJ
work_wn6awlddpbeztpigfwaxuan4au	42	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	42	3	Patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	42	4	’	’	POS
work_wn6awlddpbeztpigfwaxuan4au	42	5	self	self	NN
work_wn6awlddpbeztpigfwaxuan4au	42	6	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	42	7	reported	report	VBN
work_wn6awlddpbeztpigfwaxuan4au	42	8	data	datum	NNS
work_wn6awlddpbeztpigfwaxuan4au	42	9	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	42	10	collected	collect	VBN
work_wn6awlddpbeztpigfwaxuan4au	42	11	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	42	12	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	42	13	2008	2008	CD
work_wn6awlddpbeztpigfwaxuan4au	42	14	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	42	15	Patient	Patient	NNP
work_wn6awlddpbeztpigfwaxuan4au	42	16	Survey	Survey	NNP
work_wn6awlddpbeztpigfwaxuan4au	42	17	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	42	18	an	an	DT
work_wn6awlddpbeztpigfwaxuan4au	42	19	Internet	internet	NN
work_wn6awlddpbeztpigfwaxuan4au	42	20	survey	survey	NN
work_wn6awlddpbeztpigfwaxuan4au	42	21	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	42	22	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	42	23	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	42	24	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	43	1	We	-PRON-	PRP
work_wn6awlddpbeztpigfwaxuan4au	43	2	studied	study	VBD
work_wn6awlddpbeztpigfwaxuan4au	43	3	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	43	4	effects	effect	NNS
work_wn6awlddpbeztpigfwaxuan4au	43	5	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	43	6	aerobic	aerobic	JJ
work_wn6awlddpbeztpigfwaxuan4au	43	7	exercise	exercise	NN
work_wn6awlddpbeztpigfwaxuan4au	43	8	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	43	9	20	20	CD
work_wn6awlddpbeztpigfwaxuan4au	43	10	minutes	minute	NNS
work_wn6awlddpbeztpigfwaxuan4au	43	11	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	43	12	day	day	NN
work_wn6awlddpbeztpigfwaxuan4au	43	13	per	per	IN
work_wn6awlddpbeztpigfwaxuan4au	43	14	month	month	NN
work_wn6awlddpbeztpigfwaxuan4au	43	15	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	43	16	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	43	17	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	43	18	cigarette	cigarette	NN
work_wn6awlddpbeztpigfwaxuan4au	43	19	smoking	smoking	NN
work_wn6awlddpbeztpigfwaxuan4au	43	20	on	on	IN
work_wn6awlddpbeztpigfwaxuan4au	43	21	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	43	22	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	43	23	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	44	1	Sign	sign	NN
work_wn6awlddpbeztpigfwaxuan4au	44	2	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	44	3	symptom	symptom	NN
work_wn6awlddpbeztpigfwaxuan4au	44	4	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	44	5	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	44	6	morning	morning	NN
work_wn6awlddpbeztpigfwaxuan4au	44	7	stiffness	stiffness	NN
work_wn6awlddpbeztpigfwaxuan4au	44	8	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	44	9	fatigue	fatigue	NN
work_wn6awlddpbeztpigfwaxuan4au	44	10	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	44	11	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	44	12	pain	pain	NN
work_wn6awlddpbeztpigfwaxuan4au	44	13	are	be	VBP
work_wn6awlddpbeztpigfwaxuan4au	44	14	defi	defi	JJ
work_wn6awlddpbeztpigfwaxuan4au	44	15	ned	ned	JJ
work_wn6awlddpbeztpigfwaxuan4au	44	16	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	44	17	0	0	CD
work_wn6awlddpbeztpigfwaxuan4au	44	18	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	44	19	no	no	DT
work_wn6awlddpbeztpigfwaxuan4au	44	20	symptom	symptom	NN
work_wn6awlddpbeztpigfwaxuan4au	44	21	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	44	22	to	to	IN
work_wn6awlddpbeztpigfwaxuan4au	44	23	10	10	CD
work_wn6awlddpbeztpigfwaxuan4au	44	24	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	44	25	severe	severe	JJ
work_wn6awlddpbeztpigfwaxuan4au	44	26	symptom	symptom	NN
work_wn6awlddpbeztpigfwaxuan4au	44	27	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	44	28	within	within	IN
work_wn6awlddpbeztpigfwaxuan4au	44	29	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	44	30	survey	survey	NN
work_wn6awlddpbeztpigfwaxuan4au	44	31	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	45	1	The	the	DT
work_wn6awlddpbeztpigfwaxuan4au	45	2	Health	Health	NNP
work_wn6awlddpbeztpigfwaxuan4au	45	3	Assessment	Assessment	NNP
work_wn6awlddpbeztpigfwaxuan4au	45	4	Questionnaire	Questionnaire	NNP
work_wn6awlddpbeztpigfwaxuan4au	45	5	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	45	6	HAQ	HAQ	NNP
work_wn6awlddpbeztpigfwaxuan4au	45	7	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	45	8	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	45	9	used	use	VBN
work_wn6awlddpbeztpigfwaxuan4au	45	10	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	45	11	measure	measure	VB
work_wn6awlddpbeztpigfwaxuan4au	45	12	functional	functional	JJ
work_wn6awlddpbeztpigfwaxuan4au	45	13	status	status	NN
work_wn6awlddpbeztpigfwaxuan4au	45	14	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	45	15	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	45	16	0–3	0–3	NFP
work_wn6awlddpbeztpigfwaxuan4au	45	17	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	45	18	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	46	1	Quality	quality	NN
work_wn6awlddpbeztpigfwaxuan4au	46	2	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	46	3	life	life	NN
work_wn6awlddpbeztpigfwaxuan4au	46	4	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	46	5	measured	measure	VBN
work_wn6awlddpbeztpigfwaxuan4au	46	6	by	by	IN
work_wn6awlddpbeztpigfwaxuan4au	46	7	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	46	8	mental	mental	JJ
work_wn6awlddpbeztpigfwaxuan4au	46	9	component	component	NN
work_wn6awlddpbeztpigfwaxuan4au	46	10	score	score	NN
work_wn6awlddpbeztpigfwaxuan4au	46	11	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	46	12	MCS	MCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	46	13	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	46	14	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	46	15	physical	physical	JJ
work_wn6awlddpbeztpigfwaxuan4au	46	16	component	component	NN
work_wn6awlddpbeztpigfwaxuan4au	46	17	score	score	NN
work_wn6awlddpbeztpigfwaxuan4au	46	18	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	46	19	PCS	PCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	46	20	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	46	21	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	46	22	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	46	23	Short	Short	NNP
work_wn6awlddpbeztpigfwaxuan4au	46	24	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	46	25	Form	Form	NNP
work_wn6awlddpbeztpigfwaxuan4au	46	26	36	36	CD
work_wn6awlddpbeztpigfwaxuan4au	46	27	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	46	28	SF-36	SF-36	NNP
work_wn6awlddpbeztpigfwaxuan4au	46	29	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	46	30	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	47	1	Productivity	Productivity	NNP
work_wn6awlddpbeztpigfwaxuan4au	47	2	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	47	3	measured	measure	VBN
work_wn6awlddpbeztpigfwaxuan4au	47	4	by	by	IN
work_wn6awlddpbeztpigfwaxuan4au	47	5	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	47	6	Work	Work	NNP
work_wn6awlddpbeztpigfwaxuan4au	47	7	Productivity	Productivity	NNP
work_wn6awlddpbeztpigfwaxuan4au	47	8	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	47	9	Activity	Activity	NNP
work_wn6awlddpbeztpigfwaxuan4au	47	10	Impairment	Impairment	NNP
work_wn6awlddpbeztpigfwaxuan4au	47	11	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	47	12	WPAI	WPAI	NNP
work_wn6awlddpbeztpigfwaxuan4au	47	13	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	47	14	Scale	Scale	NNP
work_wn6awlddpbeztpigfwaxuan4au	47	15	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	48	1	There	there	EX
work_wn6awlddpbeztpigfwaxuan4au	48	2	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	48	3	no	no	DT
work_wn6awlddpbeztpigfwaxuan4au	48	4	non	non	JJ
work_wn6awlddpbeztpigfwaxuan4au	48	5	-	-	JJ
work_wn6awlddpbeztpigfwaxuan4au	48	6	RA	ra	JJ
work_wn6awlddpbeztpigfwaxuan4au	48	7	controls	control	NNS
work_wn6awlddpbeztpigfwaxuan4au	48	8	included	include	VBN
work_wn6awlddpbeztpigfwaxuan4au	48	9	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	48	10	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	48	11	study	study	NN
work_wn6awlddpbeztpigfwaxuan4au	48	12	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	49	1	RESULTS	RESULTS	NNP
work_wn6awlddpbeztpigfwaxuan4au	49	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	49	3	A	a	DT
work_wn6awlddpbeztpigfwaxuan4au	49	4	total	total	NN
work_wn6awlddpbeztpigfwaxuan4au	49	5	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	49	6	2048	2048	CD
work_wn6awlddpbeztpigfwaxuan4au	49	7	respondents	respondent	NNS
work_wn6awlddpbeztpigfwaxuan4au	49	8	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	49	9	included	include	VBN
work_wn6awlddpbeztpigfwaxuan4au	49	10	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	49	11	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	49	12	analysis	analysis	NN
work_wn6awlddpbeztpigfwaxuan4au	49	13	1001	1001	CD
work_wn6awlddpbeztpigfwaxuan4au	49	14	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	49	15	exercised	exercise	VBN
work_wn6awlddpbeztpigfwaxuan4au	49	16	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	49	17	584	584	CD
work_wn6awlddpbeztpigfwaxuan4au	49	18	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	49	19	smoked	smoke	VBD
work_wn6awlddpbeztpigfwaxuan4au	49	20	cigarettes	cigarette	NNS
work_wn6awlddpbeztpigfwaxuan4au	49	21	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	50	1	The	the	DT
work_wn6awlddpbeztpigfwaxuan4au	50	2	average	average	JJ
work_wn6awlddpbeztpigfwaxuan4au	50	3	age	age	NN
work_wn6awlddpbeztpigfwaxuan4au	50	4	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	50	5	51.9	51.9	CD
work_wn6awlddpbeztpigfwaxuan4au	50	6	years	year	NNS
work_wn6awlddpbeztpigfwaxuan4au	50	7	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	50	8	average	average	JJ
work_wn6awlddpbeztpigfwaxuan4au	50	9	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	50	10	duration	duration	NN
work_wn6awlddpbeztpigfwaxuan4au	50	11	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	50	12	11.9	11.9	CD
work_wn6awlddpbeztpigfwaxuan4au	50	13	years	year	NNS
work_wn6awlddpbeztpigfwaxuan4au	50	14	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	51	1	Patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	51	2	’	’	POS
work_wn6awlddpbeztpigfwaxuan4au	51	3	mean	mean	VBP
work_wn6awlddpbeztpigfwaxuan4au	51	4	MCS	MCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	51	5	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	51	6	PCS	PCS	NNP
work_wn6awlddpbeztpigfwaxuan4au	51	7	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	51	8	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	51	9	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	51	10	exercise	exercise	NN
work_wn6awlddpbeztpigfwaxuan4au	51	11	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	51	12	40.7	40.7	CD
work_wn6awlddpbeztpigfwaxuan4au	51	13	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	51	14	36.7	36.7	CD
work_wn6awlddpbeztpigfwaxuan4au	51	15	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	51	16	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	51	17	non	non	JJ
work_wn6awlddpbeztpigfwaxuan4au	51	18	-	-	JJ
work_wn6awlddpbeztpigfwaxuan4au	51	19	smoking	smoking	JJ
work_wn6awlddpbeztpigfwaxuan4au	51	20	groups	group	NNS
work_wn6awlddpbeztpigfwaxuan4au	51	21	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	51	22	41.2	41.2	CD
work_wn6awlddpbeztpigfwaxuan4au	51	23	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	51	24	34.4	34.4	CD
work_wn6awlddpbeztpigfwaxuan4au	51	25	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	51	26	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	51	27	signifi	signifi	VBN
work_wn6awlddpbeztpigfwaxuan4au	51	28	cantly	cantly	RB
work_wn6awlddpbeztpigfwaxuan4au	51	29	higher	high	JJR
work_wn6awlddpbeztpigfwaxuan4au	51	30	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	51	31	than	than	IN
work_wn6awlddpbeztpigfwaxuan4au	51	32	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	51	33	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	51	34	non-	non-	NN
work_wn6awlddpbeztpigfwaxuan4au	51	35	exercise	exercise	NN
work_wn6awlddpbeztpigfwaxuan4au	51	36	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	51	37	40.0	40.0	CD
work_wn6awlddpbeztpigfwaxuan4au	51	38	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	51	39	31.3	31.3	CD
work_wn6awlddpbeztpigfwaxuan4au	51	40	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	51	41	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	51	42	smoking	smoking	NN
work_wn6awlddpbeztpigfwaxuan4au	51	43	groups	group	NNS
work_wn6awlddpbeztpigfwaxuan4au	51	44	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	51	45	37.4	37.4	CD
work_wn6awlddpbeztpigfwaxuan4au	51	46	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	51	47	32.7	32.7	CD
work_wn6awlddpbeztpigfwaxuan4au	51	48	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	51	49	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	52	1	Overall	overall	JJ
work_wn6awlddpbeztpigfwaxuan4au	52	2	work	work	NN
work_wn6awlddpbeztpigfwaxuan4au	52	3	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	52	4	productivity	productivity	NN
work_wn6awlddpbeztpigfwaxuan4au	52	5	impairment	impairment	NN
work_wn6awlddpbeztpigfwaxuan4au	52	6	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	52	7	41.5	41.5	CD
work_wn6awlddpbeztpigfwaxuan4au	52	8	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	52	9	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	52	10	exercise	exercise	NN
work_wn6awlddpbeztpigfwaxuan4au	52	11	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	52	12	versus	versus	IN
work_wn6awlddpbeztpigfwaxuan4au	52	13	45.4	45.4	CD
work_wn6awlddpbeztpigfwaxuan4au	52	14	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	52	15	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	52	16	non	non	JJ
work_wn6awlddpbeztpigfwaxuan4au	52	17	-	-	JJ
work_wn6awlddpbeztpigfwaxuan4au	52	18	exercise	exercise	NN
work_wn6awlddpbeztpigfwaxuan4au	52	19	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	52	20	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	52	21	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	52	22	45.5	45.5	CD
work_wn6awlddpbeztpigfwaxuan4au	52	23	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	52	24	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	52	25	smoking	smoking	NN
work_wn6awlddpbeztpigfwaxuan4au	52	26	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	52	27	versus	versus	IN
work_wn6awlddpbeztpigfwaxuan4au	52	28	42.2	42.2	CD
work_wn6awlddpbeztpigfwaxuan4au	52	29	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	52	30	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	52	31	non	non	JJ
work_wn6awlddpbeztpigfwaxuan4au	52	32	-	-	JJ
work_wn6awlddpbeztpigfwaxuan4au	52	33	smoking	smoking	JJ
work_wn6awlddpbeztpigfwaxuan4au	52	34	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	52	35	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	53	1	Signs	sign	NNS
work_wn6awlddpbeztpigfwaxuan4au	53	2	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	53	3	symptoms	symptom	NNS
work_wn6awlddpbeztpigfwaxuan4au	53	4	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	53	5	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	53	6	HAQ	HAQ	NNP
work_wn6awlddpbeztpigfwaxuan4au	53	7	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	53	8	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	53	9	signifi	signifi	VBN
work_wn6awlddpbeztpigfwaxuan4au	53	10	cantly	cantly	RB
work_wn6awlddpbeztpigfwaxuan4au	53	11	better	well	RBR
work_wn6awlddpbeztpigfwaxuan4au	53	12	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	53	13	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	53	14	exercise	exercise	NN
work_wn6awlddpbeztpigfwaxuan4au	53	15	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	53	16	non	non	JJ
work_wn6awlddpbeztpigfwaxuan4au	53	17	-	-	JJ
work_wn6awlddpbeztpigfwaxuan4au	53	18	smoking	smoking	JJ
work_wn6awlddpbeztpigfwaxuan4au	53	19	groups	group	NNS
work_wn6awlddpbeztpigfwaxuan4au	53	20	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	53	21	all	all	DT
work_wn6awlddpbeztpigfwaxuan4au	53	22	P	p	NN
work_wn6awlddpbeztpigfwaxuan4au	53	23	0.05	0.05	CD
work_wn6awlddpbeztpigfwaxuan4au	53	24	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	53	25	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	54	1	CONCLUSIONS	conclusion	NNS
work_wn6awlddpbeztpigfwaxuan4au	54	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	54	3	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	54	4	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	54	5	who	who	WP
work_wn6awlddpbeztpigfwaxuan4au	54	6	exercise	exercise	VBP
work_wn6awlddpbeztpigfwaxuan4au	54	7	regularly	regularly	RB
work_wn6awlddpbeztpigfwaxuan4au	54	8	have	have	VBP
work_wn6awlddpbeztpigfwaxuan4au	54	9	higher	high	JJR
work_wn6awlddpbeztpigfwaxuan4au	54	10	quality	quality	NN
work_wn6awlddpbeztpigfwaxuan4au	54	11	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	54	12	life	life	NN
work_wn6awlddpbeztpigfwaxuan4au	54	13	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	54	14	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	54	15	clinical	clinical	JJ
work_wn6awlddpbeztpigfwaxuan4au	54	16	outcomes	outcome	NNS
work_wn6awlddpbeztpigfwaxuan4au	54	17	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	55	1	Those	those	DT
work_wn6awlddpbeztpigfwaxuan4au	55	2	that	that	WDT
work_wn6awlddpbeztpigfwaxuan4au	55	3	smoke	smoke	VBP
work_wn6awlddpbeztpigfwaxuan4au	55	4	cigarettes	cigarette	NNS
work_wn6awlddpbeztpigfwaxuan4au	55	5	have	have	VBP
work_wn6awlddpbeztpigfwaxuan4au	55	6	lower	low	JJR
work_wn6awlddpbeztpigfwaxuan4au	55	7	quality	quality	NN
work_wn6awlddpbeztpigfwaxuan4au	55	8	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	55	9	life	life	NN
work_wn6awlddpbeztpigfwaxuan4au	55	10	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	55	11	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	55	12	higher	high	JJR
work_wn6awlddpbeztpigfwaxuan4au	55	13	symptom/	symptom/	NN
work_wn6awlddpbeztpigfwaxuan4au	55	14	HAQ	HAQ	NNP
work_wn6awlddpbeztpigfwaxuan4au	55	15	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	55	16	suggesting	suggest	VBG
work_wn6awlddpbeztpigfwaxuan4au	55	17	that	that	IN
work_wn6awlddpbeztpigfwaxuan4au	55	18	this	this	DT
work_wn6awlddpbeztpigfwaxuan4au	55	19	habit	habit	NN
work_wn6awlddpbeztpigfwaxuan4au	55	20	may	may	MD
work_wn6awlddpbeztpigfwaxuan4au	55	21	be	be	VB
work_wn6awlddpbeztpigfwaxuan4au	55	22	detrimental	detrimental	JJ
work_wn6awlddpbeztpigfwaxuan4au	55	23	to	to	IN
work_wn6awlddpbeztpigfwaxuan4au	55	24	their	-PRON-	PRP$
work_wn6awlddpbeztpigfwaxuan4au	55	25	clinical	clinical	JJ
work_wn6awlddpbeztpigfwaxuan4au	55	26	outcomes	outcome	NNS
work_wn6awlddpbeztpigfwaxuan4au	55	27	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	56	1	These	these	DT
work_wn6awlddpbeztpigfwaxuan4au	56	2	results	result	NNS
work_wn6awlddpbeztpigfwaxuan4au	56	3	suggest	suggest	VBP
work_wn6awlddpbeztpigfwaxuan4au	56	4	that	that	IN
work_wn6awlddpbeztpigfwaxuan4au	56	5	these	these	DT
work_wn6awlddpbeztpigfwaxuan4au	56	6	lifestyle	lifestyle	NN
work_wn6awlddpbeztpigfwaxuan4au	56	7	choices	choice	NNS
work_wn6awlddpbeztpigfwaxuan4au	56	8	infl	infl	VBP
work_wn6awlddpbeztpigfwaxuan4au	56	9	uence	uence	NNP
work_wn6awlddpbeztpigfwaxuan4au	56	10	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	56	11	overall	overall	JJ
work_wn6awlddpbeztpigfwaxuan4au	56	12	risk	risk	NN
work_wn6awlddpbeztpigfwaxuan4au	56	13	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	56	14	impairment	impairment	NN
work_wn6awlddpbeztpigfwaxuan4au	56	15	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	56	16	RA	RA	NNP
work_wn6awlddpbeztpigfwaxuan4au	56	17	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	56	18	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	57	1	PMS43	PMS43	NNP
work_wn6awlddpbeztpigfwaxuan4au	57	2	IS	be	VBZ
work_wn6awlddpbeztpigfwaxuan4au	57	3	THE	the	DT
work_wn6awlddpbeztpigfwaxuan4au	57	4	HEALTH	health	NN
work_wn6awlddpbeztpigfwaxuan4au	57	5	UTILITIES	UTILITIES	NNP
work_wn6awlddpbeztpigfwaxuan4au	57	6	INDEX	index	NN
work_wn6awlddpbeztpigfwaxuan4au	57	7	VALID	valid	NN
work_wn6awlddpbeztpigfwaxuan4au	57	8	AND	and	CC
work_wn6awlddpbeztpigfwaxuan4au	57	9	RESPONSIVE	responsive	NN
work_wn6awlddpbeztpigfwaxuan4au	57	10	IN	in	IN
work_wn6awlddpbeztpigfwaxuan4au	57	11	ASSESSING	assess	VBG
work_wn6awlddpbeztpigfwaxuan4au	57	12	PATIENTS	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	57	13	WITH	with	IN
work_wn6awlddpbeztpigfwaxuan4au	57	14	ANKYLOSING	ankylosing	NN
work_wn6awlddpbeztpigfwaxuan4au	57	15	SPONDYLITIS	spondyliti	NNS
work_wn6awlddpbeztpigfwaxuan4au	57	16	?	?	.
work_wn6awlddpbeztpigfwaxuan4au	58	1	Gooch	Gooch	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	2	K1	K1	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	3	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	4	Feeny	Feeny	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	5	DH2	DH2	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	6	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	7	Wong	Wong	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	8	R3	R3	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	9	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	10	Pangan	Pangan	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	11	A1	A1	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	12	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	13	Revicki	Revicki	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	14	D4	D4	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	15	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	16	van	van	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	17	der	der	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	18	Heijde	Heijde	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	19	D5	D5	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	20	1Abbott	1Abbott	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	21	Laboratories	Laboratories	NNPS
work_wn6awlddpbeztpigfwaxuan4au	58	22	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	23	Abbott	Abbott	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	24	Park	Park	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	25	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	26	IL	IL	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	27	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	28	USA	USA	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	29	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	30	2Kaiser	2Kaiser	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	31	Permanente	Permanente	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	32	Center	Center	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	33	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	58	34	Health	Health	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	35	Research	Research	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	36	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	37	Portland	Portland	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	38	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	39	OR	or	CC
work_wn6awlddpbeztpigfwaxuan4au	58	40	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	41	USA	USA	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	42	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	43	3Abbott	3Abbott	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	44	Laboratories	Laboratories	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	45	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	46	Parsippany	Parsippany	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	47	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	48	NJ	NJ	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	49	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	50	USA	USA	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	51	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	52	4United	4United	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	53	BioSource	BioSource	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	54	Corporation	Corporation	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	55	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	56	Bethesda	Bethesda	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	57	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	58	MD	MD	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	59	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	60	USA	USA	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	61	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	62	5Leiden	5Leiden	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	63	University	University	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	64	Medical	Medical	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	65	Center	Center	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	66	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	67	Leiden	Leiden	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	68	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	58	69	Netherlands	Netherlands	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	70	OBJECTIVES	OBJECTIVES	NNP
work_wn6awlddpbeztpigfwaxuan4au	58	71	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	58	72	QALYs	qaly	NNS
work_wn6awlddpbeztpigfwaxuan4au	58	73	are	be	VBP
work_wn6awlddpbeztpigfwaxuan4au	58	74	an	an	DT
work_wn6awlddpbeztpigfwaxuan4au	58	75	important	important	JJ
work_wn6awlddpbeztpigfwaxuan4au	58	76	outcome	outcome	NN
work_wn6awlddpbeztpigfwaxuan4au	58	77	used	use	VBN
work_wn6awlddpbeztpigfwaxuan4au	58	78	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	58	79	cost	cost	NN
work_wn6awlddpbeztpigfwaxuan4au	58	80	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	58	81	effectiveness	effectiveness	NN
work_wn6awlddpbeztpigfwaxuan4au	58	82	analysis	analysis	NN
work_wn6awlddpbeztpigfwaxuan4au	58	83	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	59	1	The	the	DT
work_wn6awlddpbeztpigfwaxuan4au	59	2	Health	Health	NNP
work_wn6awlddpbeztpigfwaxuan4au	59	3	Utilities	Utilities	NNPS
work_wn6awlddpbeztpigfwaxuan4au	59	4	Index	Index	NNP
work_wn6awlddpbeztpigfwaxuan4au	59	5	Mark	Mark	NNP
work_wn6awlddpbeztpigfwaxuan4au	59	6	3	3	CD
work_wn6awlddpbeztpigfwaxuan4au	59	7	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	59	8	HUI-3	HUI-3	NNP
work_wn6awlddpbeztpigfwaxuan4au	59	9	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	59	10	is	be	VBZ
work_wn6awlddpbeztpigfwaxuan4au	59	11	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	59	12	self	self	NN
work_wn6awlddpbeztpigfwaxuan4au	59	13	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	59	14	reported	report	VBN
work_wn6awlddpbeztpigfwaxuan4au	59	15	measure	measure	NN
work_wn6awlddpbeztpigfwaxuan4au	59	16	covering	cover	VBG
work_wn6awlddpbeztpigfwaxuan4au	59	17	8	8	CD
work_wn6awlddpbeztpigfwaxuan4au	59	18	attri-	attri-	NN
work_wn6awlddpbeztpigfwaxuan4au	59	19	butes	bute	NNS
work_wn6awlddpbeztpigfwaxuan4au	59	20	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	59	21	health	health	NN
work_wn6awlddpbeztpigfwaxuan4au	59	22	status	status	NN
work_wn6awlddpbeztpigfwaxuan4au	59	23	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	60	1	Our	-PRON-	PRP$
work_wn6awlddpbeztpigfwaxuan4au	60	2	objective	objective	NN
work_wn6awlddpbeztpigfwaxuan4au	60	3	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	60	4	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	60	5	assess	assess	VB
work_wn6awlddpbeztpigfwaxuan4au	60	6	construct	construct	VB
work_wn6awlddpbeztpigfwaxuan4au	60	7	validity	validity	NN
work_wn6awlddpbeztpigfwaxuan4au	60	8	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	60	9	responsiveness	responsiveness	NN
work_wn6awlddpbeztpigfwaxuan4au	60	10	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	60	11	HUI-3	HUI-3	NNP
work_wn6awlddpbeztpigfwaxuan4au	60	12	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	60	13	ankylosing	ankylose	VBG
work_wn6awlddpbeztpigfwaxuan4au	60	14	spondylitis	spondylitis	NN
work_wn6awlddpbeztpigfwaxuan4au	60	15	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	60	16	AS	AS	NNP
work_wn6awlddpbeztpigfwaxuan4au	60	17	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	60	18	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	61	1	METHODS	methods	JJ
work_wn6awlddpbeztpigfwaxuan4au	61	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	61	3	Data	datum	NNS
work_wn6awlddpbeztpigfwaxuan4au	61	4	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	61	5	derived	derive	VBN
work_wn6awlddpbeztpigfwaxuan4au	61	6	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	61	7	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	61	8	Adalimumab	Adalimumab	NNP
work_wn6awlddpbeztpigfwaxuan4au	61	9	Trial	Trial	NNP
work_wn6awlddpbeztpigfwaxuan4au	61	10	Evaluating	Evaluating	NNP
work_wn6awlddpbeztpigfwaxuan4au	61	11	Long	Long	NNP
work_wn6awlddpbeztpigfwaxuan4au	61	12	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	61	13	Term	Term	NNP
work_wn6awlddpbeztpigfwaxuan4au	61	14	Effi	Effi	NNP
work_wn6awlddpbeztpigfwaxuan4au	61	15	cacy	cacy	NN
work_wn6awlddpbeztpigfwaxuan4au	61	16	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	61	17	Safety	safety	NN
work_wn6awlddpbeztpigfwaxuan4au	61	18	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	61	19	AS	AS	NNP
work_wn6awlddpbeztpigfwaxuan4au	61	20	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	61	21	ATLAS	ATLAS	NNP
work_wn6awlddpbeztpigfwaxuan4au	61	22	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	61	23	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	62	1	We	-PRON-	PRP
work_wn6awlddpbeztpigfwaxuan4au	62	2	speci-	speci-	VBP
work_wn6awlddpbeztpigfwaxuan4au	62	3	fi	fi	IN
work_wn6awlddpbeztpigfwaxuan4au	62	4	ed	ed	NN
work_wn6awlddpbeztpigfwaxuan4au	62	5	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	62	6	priori	priori	FW
work_wn6awlddpbeztpigfwaxuan4au	62	7	hypotheses	hypothesis	NNS
work_wn6awlddpbeztpigfwaxuan4au	62	8	regarding	regard	VBG
work_wn6awlddpbeztpigfwaxuan4au	62	9	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	62	10	direction	direction	NN
work_wn6awlddpbeztpigfwaxuan4au	62	11	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	62	12	magnitude	magnitude	NN
work_wn6awlddpbeztpigfwaxuan4au	62	13	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	62	14	associations	association	NNS
work_wn6awlddpbeztpigfwaxuan4au	62	15	expected	expect	VBN
work_wn6awlddpbeztpigfwaxuan4au	62	16	between	between	IN
work_wn6awlddpbeztpigfwaxuan4au	62	17	overall	overall	JJ
work_wn6awlddpbeztpigfwaxuan4au	62	18	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	62	19	single	single	JJ
work_wn6awlddpbeztpigfwaxuan4au	62	20	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	62	21	attribute	attribute	NN
work_wn6awlddpbeztpigfwaxuan4au	62	22	HUI-3	HUI-3	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	23	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	62	24	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	62	25	other	other	JJ
work_wn6awlddpbeztpigfwaxuan4au	62	26	health	health	NN
work_wn6awlddpbeztpigfwaxuan4au	62	27	status	status	NN
work_wn6awlddpbeztpigfwaxuan4au	62	28	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	62	29	quality	quality	NN
work_wn6awlddpbeztpigfwaxuan4au	62	30	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	62	31	life	life	NN
work_wn6awlddpbeztpigfwaxuan4au	62	32	measures	measure	NNS
work_wn6awlddpbeztpigfwaxuan4au	62	33	—	—	:
work_wn6awlddpbeztpigfwaxuan4au	62	34	SF-36	SF-36	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	35	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	62	36	ASQOL	ASQOL	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	37	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	62	38	Bath	Bath	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	39	AS	AS	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	40	Functional	Functional	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	41	Index	Index	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	42	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	62	43	BASFI	BASFI	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	44	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	62	45	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	62	46	Bath	Bath	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	47	AS	as	IN
work_wn6awlddpbeztpigfwaxuan4au	62	48	Disease	Disease	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	49	Activity	Activity	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	50	Index	Index	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	51	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	62	52	BASDAI	BASDAI	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	53	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	62	54	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	62	55	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	62	56	Patient	Patient	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	57	’s	’s	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	58	Global	Global	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	59	Assessment	Assessment	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	60	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	62	61	PGA	PGA	NNP
work_wn6awlddpbeztpigfwaxuan4au	62	62	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	62	63	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	63	1	Using	use	VBG
work_wn6awlddpbeztpigfwaxuan4au	63	2	baseline	baseline	JJ
work_wn6awlddpbeztpigfwaxuan4au	63	3	data	datum	NNS
work_wn6awlddpbeztpigfwaxuan4au	63	4	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	63	5	we	-PRON-	PRP
work_wn6awlddpbeztpigfwaxuan4au	63	6	calculated	calculate	VBD
work_wn6awlddpbeztpigfwaxuan4au	63	7	correlation	correlation	NN
work_wn6awlddpbeztpigfwaxuan4au	63	8	coeffi	coeffi	NN
work_wn6awlddpbeztpigfwaxuan4au	63	9	cients	cient	NNS
work_wn6awlddpbeztpigfwaxuan4au	63	10	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	63	11	interpreted	interpret	VBD
work_wn6awlddpbeztpigfwaxuan4au	63	12	them	-PRON-	PRP
work_wn6awlddpbeztpigfwaxuan4au	63	13	via	via	IN
work_wn6awlddpbeztpigfwaxuan4au	63	14	guidelines	guideline	NNS
work_wn6awlddpbeztpigfwaxuan4au	63	15	suggested	suggest	VBN
work_wn6awlddpbeztpigfwaxuan4au	63	16	by	by	IN
work_wn6awlddpbeztpigfwaxuan4au	63	17	Guyatt	Guyatt	NNP
work_wn6awlddpbeztpigfwaxuan4au	63	18	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	63	19	negligible	negligible	JJ
work_wn6awlddpbeztpigfwaxuan4au	63	20	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	63	21	weak	weak	JJ
work_wn6awlddpbeztpigfwaxuan4au	63	22	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	63	23	moderate	moderate	JJ
work_wn6awlddpbeztpigfwaxuan4au	63	24	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	63	25	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	63	26	strong	strong	JJ
work_wn6awlddpbeztpigfwaxuan4au	63	27	associations	association	NNS
work_wn6awlddpbeztpigfwaxuan4au	63	28	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	64	1	Responsiveness	responsiveness	NN
work_wn6awlddpbeztpigfwaxuan4au	64	2	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	64	3	assessed	assess	VBN
work_wn6awlddpbeztpigfwaxuan4au	64	4	by	by	IN
work_wn6awlddpbeztpigfwaxuan4au	64	5	calculating	calculate	VBG
work_wn6awlddpbeztpigfwaxuan4au	64	6	standardized	standardized	JJ
work_wn6awlddpbeztpigfwaxuan4au	64	7	response	response	NN
work_wn6awlddpbeztpigfwaxuan4au	64	8	means	mean	VBZ
work_wn6awlddpbeztpigfwaxuan4au	64	9	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	64	10	SRMs	SRMs	NNP
work_wn6awlddpbeztpigfwaxuan4au	64	11	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	64	12	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	64	13	HUI-3	HUI-3	NNP
work_wn6awlddpbeztpigfwaxuan4au	64	14	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	64	15	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	64	16	baseline	baseline	NN
work_wn6awlddpbeztpigfwaxuan4au	64	17	to	to	IN
work_wn6awlddpbeztpigfwaxuan4au	64	18	Week	week	NN
work_wn6awlddpbeztpigfwaxuan4au	64	19	24	24	CD
work_wn6awlddpbeztpigfwaxuan4au	64	20	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	64	21	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	64	22	meeting	meet	VBG
work_wn6awlddpbeztpigfwaxuan4au	64	23	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	64	24	minimum	minimum	JJ
work_wn6awlddpbeztpigfwaxuan4au	64	25	clinically	clinically	RB
work_wn6awlddpbeztpigfwaxuan4au	64	26	important	important	JJ
work_wn6awlddpbeztpigfwaxuan4au	64	27	differences	difference	NNS
work_wn6awlddpbeztpigfwaxuan4au	64	28	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	64	29	MCID	MCID	NNP
work_wn6awlddpbeztpigfwaxuan4au	64	30	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	64	31	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	64	32	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	64	33	ASQOL	ASQOL	NNP
work_wn6awlddpbeztpigfwaxuan4au	64	34	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	64	35	1.8	1.8	CD
work_wn6awlddpbeztpigfwaxuan4au	64	36	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	64	37	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	65	1	Responsiveness	responsiveness	JJ
work_wn6awlddpbeztpigfwaxuan4au	65	2	analysis	analysis	NN
work_wn6awlddpbeztpigfwaxuan4au	65	3	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	65	4	limited	limit	VBN
work_wn6awlddpbeztpigfwaxuan4au	65	5	to	to	IN
work_wn6awlddpbeztpigfwaxuan4au	65	6	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	65	7	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	65	8	24-week	24-week	CD
work_wn6awlddpbeztpigfwaxuan4au	65	9	HUI-3	HUI-3	NNP
work_wn6awlddpbeztpigfwaxuan4au	65	10	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	65	11	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	66	1	RESULTS	RESULTS	NNP
work_wn6awlddpbeztpigfwaxuan4au	66	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	66	3	A	a	DT
work_wn6awlddpbeztpigfwaxuan4au	66	4	total	total	NN
work_wn6awlddpbeztpigfwaxuan4au	66	5	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	66	6	295	295	CD
work_wn6awlddpbeztpigfwaxuan4au	66	7	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	66	8	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	66	9	315	315	CD
work_wn6awlddpbeztpigfwaxuan4au	66	10	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	66	11	enrolled	enrol	VBN
work_wn6awlddpbeztpigfwaxuan4au	66	12	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	66	13	ATLAS	ATLAS	NNP
work_wn6awlddpbeztpigfwaxuan4au	66	14	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	66	15	included	include	VBN
work_wn6awlddpbeztpigfwaxuan4au	66	16	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	66	17	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	66	18	analysis	analysis	NN
work_wn6awlddpbeztpigfwaxuan4au	66	19	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	67	1	Mean	mean	JJ
work_wn6awlddpbeztpigfwaxuan4au	67	2	age	age	NN
work_wn6awlddpbeztpigfwaxuan4au	67	3	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	67	4	43	43	CD
work_wn6awlddpbeztpigfwaxuan4au	67	5	years	year	NNS
work_wn6awlddpbeztpigfwaxuan4au	67	6	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	67	7	76.3	76.3	CD
work_wn6awlddpbeztpigfwaxuan4au	67	8	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	67	9	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	67	10	male	male	JJ
work_wn6awlddpbeztpigfwaxuan4au	67	11	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	67	12	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	67	13	mean	mean	VB
work_wn6awlddpbeztpigfwaxuan4au	67	14	duration	duration	NN
work_wn6awlddpbeztpigfwaxuan4au	67	15	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	67	16	AS	AS	NNP
work_wn6awlddpbeztpigfwaxuan4au	67	17	was	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	67	18	11	11	CD
work_wn6awlddpbeztpigfwaxuan4au	67	19	years	year	NNS
work_wn6awlddpbeztpigfwaxuan4au	67	20	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	68	1	Correlation	correlation	NN
work_wn6awlddpbeztpigfwaxuan4au	68	2	coeffi	coeffi	NN
work_wn6awlddpbeztpigfwaxuan4au	68	3	cients	cient	NNS
work_wn6awlddpbeztpigfwaxuan4au	68	4	between	between	IN
work_wn6awlddpbeztpigfwaxuan4au	68	5	HUI-3	HUI-3	NNP
work_wn6awlddpbeztpigfwaxuan4au	68	6	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	68	7	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	68	8	other	other	JJ
work_wn6awlddpbeztpigfwaxuan4au	68	9	instruments	instrument	NNS
work_wn6awlddpbeztpigfwaxuan4au	68	10	confi	confi	NNP
work_wn6awlddpbeztpigfwaxuan4au	68	11	rmed	rme	VBD
work_wn6awlddpbeztpigfwaxuan4au	68	12	62.2	62.2	CD
work_wn6awlddpbeztpigfwaxuan4au	68	13	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	68	14	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	68	15	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	68	16	a	a	FW
work_wn6awlddpbeztpigfwaxuan4au	68	17	priori	priori	FW
work_wn6awlddpbeztpigfwaxuan4au	68	18	hypothesis	hypothesis	NN
work_wn6awlddpbeztpigfwaxuan4au	68	19	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	68	20	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	68	21	an	an	DT
work_wn6awlddpbeztpigfwaxuan4au	68	22	additional	additional	JJ
work_wn6awlddpbeztpigfwaxuan4au	68	23	24.5	24.5	CD
work_wn6awlddpbeztpigfwaxuan4au	68	24	%	%	NN
work_wn6awlddpbeztpigfwaxuan4au	68	25	being	be	VBG
work_wn6awlddpbeztpigfwaxuan4au	68	26	under-	under-	NN
work_wn6awlddpbeztpigfwaxuan4au	68	27	or	or	CC
work_wn6awlddpbeztpigfwaxuan4au	68	28	over	over	RB
work_wn6awlddpbeztpigfwaxuan4au	68	29	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	68	30	estimated	estimate	VBN
work_wn6awlddpbeztpigfwaxuan4au	68	31	by	by	IN
work_wn6awlddpbeztpigfwaxuan4au	68	32	only	only	RB
work_wn6awlddpbeztpigfwaxuan4au	68	33	one	one	CD
work_wn6awlddpbeztpigfwaxuan4au	68	34	category	category	NN
work_wn6awlddpbeztpigfwaxuan4au	68	35	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	69	1	Results	result	NNS
work_wn6awlddpbeztpigfwaxuan4au	69	2	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	69	3	responsiveness	responsiveness	JJ
work_wn6awlddpbeztpigfwaxuan4au	69	4	analysis	analysis	NN
work_wn6awlddpbeztpigfwaxuan4au	69	5	demonstrated	demonstrate	VBD
work_wn6awlddpbeztpigfwaxuan4au	69	6	that	that	IN
work_wn6awlddpbeztpigfwaxuan4au	69	7	there	there	EX
work_wn6awlddpbeztpigfwaxuan4au	69	8	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	69	9	signifi	signifi	NN
work_wn6awlddpbeztpigfwaxuan4au	69	10	ca	can	MD
work_wn6awlddpbeztpigfwaxuan4au	69	11	nt	not	RB
work_wn6awlddpbeztpigfwaxuan4au	69	12	differences	difference	NNS
work_wn6awlddpbeztpigfwaxuan4au	69	13	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	69	14	overall	overall	JJ
work_wn6awlddpbeztpigfwaxuan4au	69	15	HUI-3	HUI-3	NNP
work_wn6awlddpbeztpigfwaxuan4au	69	16	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	69	17	SRM	SRM	NNP
work_wn6awlddpbeztpigfwaxuan4au	69	18	1.13	1.13	CD
work_wn6awlddpbeztpigfwaxuan4au	69	19	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	69	20	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	69	21	most	most	RBS
work_wn6awlddpbeztpigfwaxuan4au	69	22	single	single	JJ
work_wn6awlddpbeztpigfwaxuan4au	69	23	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	69	24	attribute	attribute	NN
work_wn6awlddpbeztpigfwaxuan4au	69	25	change	change	NN
work_wn6awlddpbeztpigfwaxuan4au	69	26	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	69	27	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	69	28	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	69	29	whose	whose	WP$
work_wn6awlddpbeztpigfwaxuan4au	69	30	changes	change	NNS
work_wn6awlddpbeztpigfwaxuan4au	69	31	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	69	32	greater	great	JJR
work_wn6awlddpbeztpigfwaxuan4au	69	33	than	than	IN
work_wn6awlddpbeztpigfwaxuan4au	69	34	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	69	35	ASQOL	ASQOL	NNP
work_wn6awlddpbeztpigfwaxuan4au	69	36	MCID	MCID	NNP
work_wn6awlddpbeztpigfwaxuan4au	69	37	vs.	vs.	IN
work_wn6awlddpbeztpigfwaxuan4au	69	38	those	those	DT
work_wn6awlddpbeztpigfwaxuan4au	69	39	whose	whose	WP$
work_wn6awlddpbeztpigfwaxuan4au	69	40	changes	change	NNS
work_wn6awlddpbeztpigfwaxuan4au	69	41	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	69	42	MCID	MCID	NNP
work_wn6awlddpbeztpigfwaxuan4au	69	43	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	70	1	CONCLUSIONS	conclusion	NNS
work_wn6awlddpbeztpigfwaxuan4au	70	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	70	3	These	these	DT
work_wn6awlddpbeztpigfwaxuan4au	70	4	results	result	NNS
work_wn6awlddpbeztpigfwaxuan4au	70	5	suggest	suggest	VBP
work_wn6awlddpbeztpigfwaxuan4au	70	6	that	that	IN
work_wn6awlddpbeztpigfwaxuan4au	70	7	HUI-3	HUI-3	NNP
work_wn6awlddpbeztpigfwaxuan4au	70	8	constructs	construct	NNS
work_wn6awlddpbeztpigfwaxuan4au	70	9	are	be	VBP
work_wn6awlddpbeztpigfwaxuan4au	70	10	related	relate	VBN
work_wn6awlddpbeztpigfwaxuan4au	70	11	to	to	IN
work_wn6awlddpbeztpigfwaxuan4au	70	12	similar	similar	JJ
work_wn6awlddpbeztpigfwaxuan4au	70	13	constructs	construct	NNS
work_wn6awlddpbeztpigfwaxuan4au	70	14	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	70	15	other	other	JJ
work_wn6awlddpbeztpigfwaxuan4au	70	16	measures	measure	NNS
work_wn6awlddpbeztpigfwaxuan4au	70	17	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	70	18	as	as	IN
work_wn6awlddpbeztpigfwaxuan4au	70	19	expected	expect	VBN
work_wn6awlddpbeztpigfwaxuan4au	70	20	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	71	1	This	this	DT
work_wn6awlddpbeztpigfwaxuan4au	71	2	study	study	NN
work_wn6awlddpbeztpigfwaxuan4au	71	3	provides	provide	VBZ
work_wn6awlddpbeztpigfwaxuan4au	71	4	evidence	evidence	NN
work_wn6awlddpbeztpigfwaxuan4au	71	5	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	71	6	cross	cross	JJ
work_wn6awlddpbeztpigfwaxuan4au	71	7	-	-	JJ
work_wn6awlddpbeztpigfwaxuan4au	71	8	sectional	sectional	JJ
work_wn6awlddpbeztpigfwaxuan4au	71	9	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	71	10	longitudinal	longitudinal	JJ
work_wn6awlddpbeztpigfwaxuan4au	71	11	construct	construct	NN
work_wn6awlddpbeztpigfwaxuan4au	71	12	validity	validity	NN
work_wn6awlddpbeztpigfwaxuan4au	71	13	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	71	14	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	71	15	HUI-3	HUI-3	NNP
work_wn6awlddpbeztpigfwaxuan4au	71	16	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	71	17	deriving	derive	VBG
work_wn6awlddpbeztpigfwaxuan4au	71	18	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	71	19	scores	score	NNS
work_wn6awlddpbeztpigfwaxuan4au	71	20	for	for	IN
work_wn6awlddpbeztpigfwaxuan4au	71	21	AS	AS	NNP
work_wn6awlddpbeztpigfwaxuan4au	71	22	patients	patient	NNS
work_wn6awlddpbeztpigfwaxuan4au	71	23	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	72	1	PMS44	PMS44	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	2	VALIDATION	VALIDATION	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	3	OF	of	IN
work_wn6awlddpbeztpigfwaxuan4au	72	4	THE	the	DT
work_wn6awlddpbeztpigfwaxuan4au	72	5	MULTI	MULTI	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	6	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	72	7	ATTRIBUTE	ATTRIBUTE	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	8	HEALTH	HEALTH	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	9	UTILITY	UTILITY	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	10	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	72	11	MAHU	MAHU	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	12	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	72	13	DERIVED	derive	VBD
work_wn6awlddpbeztpigfwaxuan4au	72	14	FROM	from	IN
work_wn6awlddpbeztpigfwaxuan4au	72	15	A	a	DT
work_wn6awlddpbeztpigfwaxuan4au	72	16	COMPUTER	computer	NN
work_wn6awlddpbeztpigfwaxuan4au	72	17	ADAPTIVE	adaptive	NN
work_wn6awlddpbeztpigfwaxuan4au	72	18	INSTRUMENT	instrument	NN
work_wn6awlddpbeztpigfwaxuan4au	72	19	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	20	CAT-5D	CAT-5D	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	21	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	72	22	QOL	QOL	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	23	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	24	IN	in	IN
work_wn6awlddpbeztpigfwaxuan4au	72	25	OSTEOARTHRITIS	OSTEOARTHRITIS	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	26	Kang	Kang	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	27	Wg	Wg	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	28	1	1	CD
work_wn6awlddpbeztpigfwaxuan4au	72	29	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	30	Sayre	Sayre	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	31	EC2	EC2	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	32	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	33	Steininger	Steininger	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	34	G1	G1	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	35	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	36	Doerfl	Doerfl	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	37	ing	ing	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	38	P3	P3	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	39	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	40	Ratzlaff	Ratzlaff	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	41	C1	C1	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	42	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	43	Esdaile	Esdaile	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	44	J3	J3	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	45	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	46	Kopec	Kopec	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	47	J3	J3	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	48	1University	1University	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	49	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	72	50	British	British	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	51	Columbia	Columbia	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	52	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	53	Vancouver	Vancouver	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	54	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	55	BC	BC	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	56	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	57	Canada	Canada	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	58	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	59	2Arthritis	2Arthritis	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	60	Research	Research	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	61	Centre	Centre	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	62	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	72	63	Canada	Canada	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	64	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	72	65	Simon	Simon	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	66	Fraser	Fraser	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	67	University	University	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	68	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	69	Vancouver	Vancouver	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	70	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	71	BC	BC	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	72	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	73	Canada	Canada	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	74	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	75	3Arthritis	3Arthritis	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	76	Research	Research	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	77	Centre	Centre	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	78	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	72	79	Canada	Canada	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	80	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	81	Vancouver	Vancouver	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	82	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	83	BC	BC	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	84	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	85	Canada	Canada	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	86	OBJECTIVES	OBJECTIVES	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	87	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	72	88	We	-PRON-	PRP
work_wn6awlddpbeztpigfwaxuan4au	72	89	aimed	aim	VBD
work_wn6awlddpbeztpigfwaxuan4au	72	90	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	72	91	validate	validate	VB
work_wn6awlddpbeztpigfwaxuan4au	72	92	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	72	93	multi	multi	JJ
work_wn6awlddpbeztpigfwaxuan4au	72	94	-	-	JJ
work_wn6awlddpbeztpigfwaxuan4au	72	95	attribute	attribute	JJ
work_wn6awlddpbeztpigfwaxuan4au	72	96	health	health	NN
work_wn6awlddpbeztpigfwaxuan4au	72	97	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	72	98	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	72	99	MAHU	MAHU	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	100	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	72	101	derived	derive	VBD
work_wn6awlddpbeztpigfwaxuan4au	72	102	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	72	103	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	72	104	CAT-5D	CAT-5D	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	105	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	72	106	QOL	QOL	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	107	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	108	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	72	109	computer	computer	NN
work_wn6awlddpbeztpigfwaxuan4au	72	110	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	72	111	adaptive	adaptive	JJ
work_wn6awlddpbeztpigfwaxuan4au	72	112	instrument	instrument	NN
work_wn6awlddpbeztpigfwaxuan4au	72	113	composed	compose	VBN
work_wn6awlddpbeztpigfwaxuan4au	72	114	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	72	115	5	5	CD
work_wn6awlddpbeztpigfwaxuan4au	72	116	domains	domain	NNS
work_wn6awlddpbeztpigfwaxuan4au	72	117	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	72	118	Walking	walk	VBG
work_wn6awlddpbeztpigfwaxuan4au	72	119	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	120	Handling	Handling	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	121	Objects	Objects	NNPS
work_wn6awlddpbeztpigfwaxuan4au	72	122	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	123	Daily	Daily	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	124	Activities	Activities	NNPS
work_wn6awlddpbeztpigfwaxuan4au	72	125	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	126	Pain	Pain	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	127	/	/	SYM
work_wn6awlddpbeztpigfwaxuan4au	72	128	Discomfort	Discomfort	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	129	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	130	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	72	131	Feelings	feeling	NNS
work_wn6awlddpbeztpigfwaxuan4au	72	132	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	72	133	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	72	134	people	people	NNS
work_wn6awlddpbeztpigfwaxuan4au	72	135	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	72	136	self	self	NN
work_wn6awlddpbeztpigfwaxuan4au	72	137	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	72	138	reported	report	VBN
work_wn6awlddpbeztpigfwaxuan4au	72	139	osteoarthritis	osteoarthritis	NN
work_wn6awlddpbeztpigfwaxuan4au	72	140	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	72	141	OA	OA	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	142	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	72	143	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	144	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	72	145	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	72	146	compare	compare	VB
work_wn6awlddpbeztpigfwaxuan4au	72	147	it	-PRON-	PRP
work_wn6awlddpbeztpigfwaxuan4au	72	148	with	with	IN
work_wn6awlddpbeztpigfwaxuan4au	72	149	WOMAC_HUI3	WOMAC_HUI3	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	150	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	72	151	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	72	152	utility	utility	NN
work_wn6awlddpbeztpigfwaxuan4au	72	153	derived	derive	VBN
work_wn6awlddpbeztpigfwaxuan4au	72	154	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	72	155	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	72	156	standard	standard	JJ
work_wn6awlddpbeztpigfwaxuan4au	72	157	disease	disease	NN
work_wn6awlddpbeztpigfwaxuan4au	72	158	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	72	159	specifi	specifi	NN
work_wn6awlddpbeztpigfwaxuan4au	72	160	c	c	NN
work_wn6awlddpbeztpigfwaxuan4au	72	161	measure	measure	NN
work_wn6awlddpbeztpigfwaxuan4au	72	162	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	72	163	OA	OA	NNP
work_wn6awlddpbeztpigfwaxuan4au	72	164	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	73	1	METHODS	methods	JJ
work_wn6awlddpbeztpigfwaxuan4au	73	2	:	:	:
work_wn6awlddpbeztpigfwaxuan4au	73	3	Data	datum	NNS
work_wn6awlddpbeztpigfwaxuan4au	73	4	were	be	VBD
work_wn6awlddpbeztpigfwaxuan4au	73	5	collected	collect	VBN
work_wn6awlddpbeztpigfwaxuan4au	73	6	from	from	IN
work_wn6awlddpbeztpigfwaxuan4au	73	7	participants	participant	NNS
work_wn6awlddpbeztpigfwaxuan4au	73	8	(	(	-LRB-
work_wn6awlddpbeztpigfwaxuan4au	73	9	age	age	NN
work_wn6awlddpbeztpigfwaxuan4au	73	10	50	50	CD
work_wn6awlddpbeztpigfwaxuan4au	73	11	)	)	-RRB-
work_wn6awlddpbeztpigfwaxuan4au	73	12	who	who	WP
work_wn6awlddpbeztpigfwaxuan4au	73	13	completed	complete	VBD
work_wn6awlddpbeztpigfwaxuan4au	73	14	questionnaires	questionnaire	NNS
work_wn6awlddpbeztpigfwaxuan4au	73	15	CAT-5D-	CAT-5D-	NNP
work_wn6awlddpbeztpigfwaxuan4au	73	16	QOL	qol	NN
work_wn6awlddpbeztpigfwaxuan4au	73	17	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	73	18	two	two	CD
work_wn6awlddpbeztpigfwaxuan4au	73	19	waves	wave	NNS
work_wn6awlddpbeztpigfwaxuan4au	73	20	and	and	CC
work_wn6awlddpbeztpigfwaxuan4au	73	21	WOMAC	WOMAC	NNP
work_wn6awlddpbeztpigfwaxuan4au	73	22	in	in	IN
work_wn6awlddpbeztpigfwaxuan4au	73	23	one	one	CD
work_wn6awlddpbeztpigfwaxuan4au	73	24	wave	wave	NN
work_wn6awlddpbeztpigfwaxuan4au	73	25	of	of	IN
work_wn6awlddpbeztpigfwaxuan4au	73	26	a	a	DT
work_wn6awlddpbeztpigfwaxuan4au	73	27	Canada	Canada	NNP
work_wn6awlddpbeztpigfwaxuan4au	73	28	-	-	HYPH
work_wn6awlddpbeztpigfwaxuan4au	73	29	wide	wide	JJ
work_wn6awlddpbeztpigfwaxuan4au	73	30	online	online	JJ
work_wn6awlddpbeztpigfwaxuan4au	73	31	survey	survey	NN
work_wn6awlddpbeztpigfwaxuan4au	73	32	.	.	.
work_wn6awlddpbeztpigfwaxuan4au	74	1	To	to	TO
work_wn6awlddpbeztpigfwaxuan4au	74	2	assess	assess	VB
work_wn6awlddpbeztpigfwaxuan4au	74	3	construct	construct	NN
work_wn6awlddpbeztpigfwaxuan4au	74	4	validity	validity	NN
work_wn6awlddpbeztpigfwaxuan4au	74	5	,	,	,
work_wn6awlddpbeztpigfwaxuan4au	74	6	we	-PRON-	PRP
work_wn6awlddpbeztpigfwaxuan4au	74	7	used	use	VBD
work_wn6awlddpbeztpigfwaxuan4au	74	8	multivariable	multivariable	JJ
work_wn6awlddpbeztpigfwaxuan4au	74	9	regression	regression	NN
work_wn6awlddpbeztpigfwaxuan4au	74	10	to	to	TO
work_wn6awlddpbeztpigfwaxuan4au	74	11	examine	examine	VB
work_wn6awlddpbeztpigfwaxuan4au	74	12	the	the	DT
work_wn6awlddpbeztpigfwaxuan4au	74	13	associations	association	NNS